<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">zZPt7RFWrCJ9xYFZJVxhTxr</article-id>
      <article-id pub-id-type="other">00008</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2008001800008</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(08)09100608</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2008001800008</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Preval&#234;ncia e fatores de risco associados &#224; doen&#231;a arterial perif&#233;rica no projeto cora&#231;&#245;es do Brasil</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Makdisse</surname>
            <given-names>Marcia</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pereira</surname>
            <given-names>Alexandre da Costa</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brasil</surname>
            <given-names>David de P&#225;dua</given-names>
          </name>
          <xref ref-type="aff" rid="aff04"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Borges</surname>
            <given-names>Jairo Lins</given-names>
          </name>
          <xref ref-type="aff" rid="aff05"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Machado-Coelho</surname>
            <given-names>George Luiz Lins</given-names>
          </name>
          <xref ref-type="aff" rid="aff06"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Krieger</surname>
            <given-names>Jos&#233; Eduardo</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nascimento Neto</surname>
            <given-names>Raimundo Marques</given-names>
          </name>
          <xref ref-type="aff" rid="aff06"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chagas</surname>
            <given-names>Antonio Carlos Palandri</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">SP</named-content>
        </addr-line>
        <institution content-type="orgname">Hospital Israelita Albert Einstein</institution>
        <country country="BR">Brasil</country>
      </aff>
      <aff id="aff05">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Instituto Dante Pazzanese de Cardiologia</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff03">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">Faculdade de Medicina </institution>
        <institution content-type="orgdiv2">Instituto do Cora&#231;&#227;o</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff04">
        <addr-line>
          <named-content content-type="city">Belo Horizonte</named-content>
          <named-content content-type="state">Minas Gerais</named-content>
        </addr-line>
        <institution content-type="orgname">Faculdade de Ci&#234;ncias M&#233;dicas de Minas Gerais</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff06">
        <addr-line>
          <named-content content-type="city">Ouro Preto</named-content>
          <named-content content-type="state">MG</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal de Ouro Preto</institution>
        <institution content-type="orgdiv1">Departamento de Ci&#234;ncias M&#233;dicas </institution>
        <country country="BR">Brasil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal de S&#227;o Paulo</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>12</month>
        <year>2008</year>
      </pub-date>
      <volume>91</volume>
      <issue>6</issue>
      <fpage>402</fpage>
      <lpage>414</lpage>
      <history>
        <date date-type="accepted">
          <day>15</day>
          <month>08</month>
          <year>2008</year>
        </date>
        <date date-type="rev-recd">
          <day>06</day>
          <month>08</month>
          <year>2008</year>
        </date>
        <date date-type="received">
          <day>30</day>
          <month>06</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: A doen&#231;a arterial obstrutiva perif&#233;rica (DAOP) est&#225; associada ao maior &#237;ndice de risco cardiovascular. No Brasil, faltam dados sobre sua preval&#234;ncia e fatores de risco. OBJETIVO: Avaliar preval&#234;ncia e fatores de risco associados &#224; DAOP nas cidades brasileiras com &gt; cem mil habitantes. M&#201;TODOS: Estudo transversal, multic&#234;ntrico, que avaliou 1.170 indiv&#237;duos (&gt;18 anos), em 72 centros urbanos, participantes do Projeto Cora&#231;&#245;es do Brasil. O diagn&#243;stico de DAOP baseou-se na medida do &#237;ndice tornozelo-braquial (ITB) &lt; 0,90. A an&#225;lise estat&#237;stica utilizou teste Qui-quadrado (Pearson) corrigido para amostras complexas e intervalos de confian&#231;a. P &lt; 0,05 foi considerado significativo. RESULTADOS: A preval&#234;ncia de DAOP foi de 10,5% e apenas 9% dos portadores da doen&#231;a apresentaram claudica&#231;&#227;o. A DAOP esteve associada &#224; presen&#231;a de diabetes, obesidade total e abdominal, acidente vascular cerebral (AVC) e doen&#231;a isqu&#234;mica do cora&#231;&#227;o (DIC). Houve tend&#234;ncia a maior preval&#234;ncia de DAOP na presen&#231;a de hipertens&#227;o, insufici&#234;ncia card&#237;aca, insufici&#234;ncia renal dial&#237;tica e tabagismo &gt;20 anos/ma&#231;o. Mulheres coronariopatas apresentaram risco 4,9 vezes maior de ter DAOP, do que aquelas sem coronariopatia e, entre homens diab&#233;ticos, o risco de DAOP foi 6,6 maior em compara&#231;&#227;o aos n&#227;o diab&#233;ticos. CONCLUS&#195;O: A preval&#234;ncia de DAOP foi elevada, considerando-se a baixa m&#233;dia de idade da popula&#231;&#227;o avaliada (44&#177;14,7 anos). A minoria dos portadores apresentava claudica&#231;&#227;o, o que denota o grande contingente de indiv&#237;duos assintom&#225;ticos. Os fatores mais fortemente associados &#224; doen&#231;a foram diabetes, obesidade, AVC e DIC. Os autores conclu&#237;ram que a medida do ITB deve ser considerada na avalia&#231;&#227;o de pacientes de moderado e alto risco cardiovascular.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>arteriopatias oclusivas</kwd>
        <kwd>preval&#234;ncia</kwd>
        <kwd>fatores de risco</kwd>
        <kwd>Brasil</kwd>
        <kwd>claudica&#231;&#227;o intermitente</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>05</day>
        <month>01</month>
        <year>2009</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>ARTIGO ORIGINAL </p>
    <p> EPIDEMIOLOGIA</p>
    <p>Preval&#234;ncia e fatores de risco associados &#224; doen&#231;a arterial perif&#233;rica no projeto cora&#231;&#245;es do Brasil</p>
    <p>
      <bold>Marcia Makdisse<sup>I, II</sup>; Alexandre da Costa Pereira<sup>III</sup>; David de P&#225;dua Brasil<sup>IV</sup>; Jairo Lins Borges<sup>V</sup>; George Luiz Lins Machado-Coelho<sup>VI</sup>; Jos&#233; Eduardo Krieger<sup>III</sup>; Raimundo Marques Nascimento Neto<sup>VI</sup>; Antonio Carlos Palandri Chagas<sup>III</sup>; representando os investigadores do Projeto Cora&#231;&#245;es do Brasil e do Comit&#234; de Doen&#231;a Arterial Perif&#233;rica da Sociedade Brasileira de Cardiologia - SBC/Funcor</bold>
    </p>
    <p><sup>I</sup>Hospital Israelita Albert Einstein, S&#227;o Paulo, SP - Brasil </p>
    <p><sup>II</sup>Universidade Federal de S&#227;o Paulo (Unifesp), S&#227;o Paulo, SP - Brasil </p>
    <p><sup>III</sup>Instituto do Cora&#231;&#227;o da Faculdade de Medicina da Universidade de S&#227;o Paulo (Incor USP), S&#227;o Paulo, SP - Brasil </p>
    <p><sup>IV</sup>Faculdade de Ci&#234;ncias M&#233;dicas de Minas Gerais, Belo Horizonte, MG - Brasil </p>
    <p><sup>V</sup>Instituto Dante Pazzanese de Cardiologia, S&#227;o Paulo, SP - Brasil </p>
    <p><sup>VI</sup>Departamento de Ci&#234;ncias M&#233;dicas da Universidade Federal de Ouro Preto, Ouro Preto, MG - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="end">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO:</bold> A doen&#231;a arterial obstrutiva perif&#233;rica (DAOP) est&#225; associada ao maior &#237;ndice de risco cardiovascular. No Brasil, faltam dados sobre sua preval&#234;ncia e fatores de risco. </p>
    <p><bold>OBJETIVO:</bold> Avaliar preval&#234;ncia e fatores de risco associados &#224; DAOP nas cidades brasileiras com <underline>&gt;</underline> cem mil habitantes. </p>
    <p><bold>M&#201;TODOS:</bold> Estudo transversal, multic&#234;ntrico, que avaliou 1.170 indiv&#237;duos (<underline>&gt;</underline>18 anos), em 72 centros urbanos, participantes do Projeto Cora&#231;&#245;es do Brasil. O diagn&#243;stico de DAOP baseou-se na medida do &#237;ndice tornozelo-braquial (ITB) <underline>&lt;</underline> 0,90. A an&#225;lise estat&#237;stica utilizou teste Qui-quadrado (Pearson) corrigido para amostras complexas e intervalos de confian&#231;a. P &lt; 0,05 foi considerado significativo. </p>
    <p><bold>RESULTADOS:</bold> A preval&#234;ncia de DAOP foi de 10,5% e apenas 9% dos portadores da doen&#231;a apresentaram claudica&#231;&#227;o. A DAOP esteve associada &#224; presen&#231;a de diabetes, obesidade total e abdominal, acidente vascular cerebral (AVC) e doen&#231;a isqu&#234;mica do cora&#231;&#227;o (DIC). Houve tend&#234;ncia a maior preval&#234;ncia de DAOP na presen&#231;a de hipertens&#227;o, insufici&#234;ncia card&#237;aca, insufici&#234;ncia renal dial&#237;tica e tabagismo &gt;20 anos/ma&#231;o. Mulheres coronariopatas apresentaram risco 4,9 vezes maior de ter DAOP, do que aquelas sem coronariopatia e, entre homens diab&#233;ticos, o risco de DAOP foi 6,6 maior em compara&#231;&#227;o aos n&#227;o diab&#233;ticos. </p>
    <p><bold>CONCLUS&#195;O:</bold> A preval&#234;ncia de DAOP foi elevada, considerando-se a baixa m&#233;dia de idade da popula&#231;&#227;o avaliada (44&#177;14,7 anos). A minoria dos portadores apresentava claudica&#231;&#227;o, o que denota o grande contingente de indiv&#237;duos assintom&#225;ticos. Os fatores mais fortemente associados &#224; doen&#231;a foram diabetes, obesidade, AVC e DIC. Os autores conclu&#237;ram que a medida do ITB deve ser considerada na avalia&#231;&#227;o de pacientes de moderado e alto risco cardiovascular.</p>
    <p><bold>Palavras-chave:</bold> arteriopatias oclusivas, preval&#234;ncia, fatores de risco, Brasil, claudica&#231;&#227;o intermitente.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>Estima-se em 27 milh&#245;es o n&#250;mero de portadores de doen&#231;a arterial obstrutiva perif&#233;rica (DAOP) na Europa e na Am&#233;rica do Norte<sup>1</sup>. Esse n&#250;mero pode estar subestimado, j&#225; que a maioria dos pacientes &#233; assintom&#225;tica ou n&#227;o apresenta o sintoma cl&#225;ssico da doen&#231;a, a claudica&#231;&#227;o intermitente<sup>2</sup>.</p>
    <p>A DAOP, tanto sintom&#225;tica quanto assintom&#225;tica, est&#225; associada &#224; doen&#231;a arterial obstrutiva em outros leitos vasculares (coronariano, cerebral, carot&#237;deo) e, por conseguinte, ao maior risco de eventos cardiovasculares (morte, infarto agudo do mioc&#225;rdio, acidente vascular cerebral), na ordem de 4 a 6% ao ano, em portadores da doen&#231;a<sup>3-5</sup>.</p>
    <p>O rastreamento da DAOP assintom&#225;tica, por meio do &#237;ndice tornozelo-braquial (ITB), tem se tornado um importante aliado na estratifica&#231;&#227;o do risco cardiovascular, especialmente nos pacientes de risco intermedi&#225;rio<sup>6-7</sup>.</p>
    <p>No Brasil, os dados relacionados &#224; preval&#234;ncia de DAOP e seus fatores de risco s&#227;o escassos e restritos a popula&#231;&#245;es espec&#237;ficas, praticamente todos realizados na Regi&#227;o Sudeste do pa&#237;s. Dentre eles, destacam-se dois estudos de base populacional: O Projeto Bambu&#237;, que avaliou 1.485 idosos (<underline>&gt;</underline> 65 anos) residentes em Bambu&#237; (Minas Gerais), e demonstrou preval&#234;ncia de 2,5% de claudica&#231;&#227;o intermitente<sup>8</sup> e o Estudo Epidoso, que avaliou por meio do ITB, 176 idosos (<underline>&gt;</underline> 75 anos) residentes na cidade de S&#227;o Paulo e encontrou preval&#234;ncia de 36,4% de DAOP<sup>9</sup>. Um estudo mais recente, tamb&#233;m realizado em Minas Gerais, encontrou 37,5% de DAOP entre portadores de doen&#231;a renal cr&#244;nica pr&#233;-dial&#237;tica<sup>10</sup>.</p>
    <p>Diante do exposto, o objetivo prim&#225;rio desse estudo foi avaliar, por meio do ITB, a preval&#234;ncia de DAOP sintom&#225;tica e assintom&#225;tica em amostra populacional proporcional, proveniente de 72 centros urbanos brasileiros com popula&#231;&#227;o superior a cem mil habitantes. O objetivo secund&#225;rio foi correlacionar o diagn&#243;stico da DAOP a diversas vari&#225;veis s&#243;cio-demogr&#225;ficas, presen&#231;a de fatores de risco cardiovascular e presen&#231;a de co-morbidades.</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>
      <bold>Desenho do estudo</bold>
    </p>
    <p>Estudo de corte transversal, observacional, multic&#234;ntrico.</p>
    <p>
      <bold>Popula&#231;&#227;o</bold>
    </p>
    <p>A pesquisa se restringiu ao conjunto dos habitantes das cidades brasileiras com mais de cem mil habitantes em 2004, com idade <underline>&gt;</underline> 18 anos.</p>
    <p>
      <bold>Plano amostral</bold>
    </p>
    <p>Trata-se de amostra estratificada, com amostragem biet&#225;pica, calculada em 2.500 entrevistas, distribu&#237;das nas Regi&#245;es proporcionalmente ao n&#250;mero de habitantes, por sexo e faixa et&#225;ria, com base nos dados do IBGE (Instituto Brasileiro de Geografia e Estat&#237;stica). Foram escolhidas 72 cidades nas cinco regi&#245;es. O tamanho m&#237;nimo de amostra foi fixado em 15 para cidades menores, e em at&#233; quatrocentos para a cidade de S&#227;o Paulo. Nas cidades selecionadas, os "domic&#237;lios" constitu&#237;ram as unidades de segundo est&#225;gio, com uma entrevista em cada domic&#237;lio.</p>
    <p>A escolha do indiv&#237;duo ocorreu em tr&#234;s est&#225;gios. Nas cidades, foram selecionados os setores censit&#225;rios. Nos setores, foi eleita uma rua e, seguindo-se regras de aleatoriza&#231;&#227;o (in&#237;cio aleat&#243;rio e intervalo fixo de 10 domic&#237;lios), foi escolhido o domic&#237;lio. O entrevistado foi selecionado com base em crit&#233;rios pr&#233;-definidos (data de anivers&#225;rio mais pr&#243;xima &#224; da entrevista), respeitando-se a estratifica&#231;&#227;o por sexo e idade. Caso n&#227;o estivesse presente no primeiro contato, poderia ser amostrado em duas visitas subseq&#252;entes em outra data, pelo mesmo entrevistador. Os entrevistados foram convidados a comparecer a uma consulta m&#233;dica em dia apropriado. O planejamento previu de 7 a 8 entrevistas por setor censit&#225;rio, caracterizando um terceiro est&#225;gio no plano amostral.</p>
    <p>
      <bold>Amostra observada</bold>
    </p>
    <p>De um total de 2.520 entrevistas domiciliares, 1.134 pessoas compareceram para os exames m&#233;dicos. O n&#250;mero de pessoas avaliadas n&#227;o acompanhou o mesmo n&#250;mero da amostra domiciliar, e algumas cidades n&#227;o tiveram volunt&#225;rios para a segunda etapa. Conseq&#252;entemente, uma amostra suplementar foi realizada, com 498 entrevistas telef&#244;nicas, em S&#227;o Paulo, Rio de Janeiro, Belo Horizonte e Florian&#243;polis. Nestas cidades, 141 pessoas compareceram para realiza&#231;&#227;o de exames m&#233;dicos. Duas cidades - Manaus e Vit&#243;ria - foram desconsideradas das an&#225;lises dos fatores de risco por terem apenas uma pessoa nessa amostra. A amostra com medida de ITB e informa&#231;&#245;es dos fatores de risco foi de 1.170 indiv&#237;duos.</p>
    <p>O Projeto foi aprovado pelo Comit&#234; de &#233;tica em Pesquisa do Instituto de Hipertens&#227;o Arterial de Minas Gerais e, por orienta&#231;&#227;o da Comiss&#227;o Nacional de &#201;tica em Pesquisa (CONEP), foi submetido e aprovado pelo Conselho Nacional dos Secret&#225;rios Municipais de Sa&#250;de (CONASEMS), que atuou facilitando o contato dos pesquisadores de campo com os Secret&#225;rios Municipais de Sa&#250;de. Todos os participantes assinaram termo de consentimento esclarecido.</p>
    <p>
      <bold>Coleta de dados</bold>
    </p>
    <p>A coleta ocorreu em duas etapas. A primeira, iniciada em julho/2004, foi realizada por profissionais do Instituto de Pesquisa Vox Populi que aplicaram question&#225;rios estruturados em entrevista domiciliar. Na segunda etapa, realizou-se uma consulta m&#233;dica padronizada, com question&#225;rios m&#233;dicos, exame cl&#237;nico, medidas de press&#227;o arterial, antropometria, ITB e coleta de material biol&#243;gico.</p>
    <p>
      <bold>Rastreamento da DAOP</bold>
    </p>
    <p>O rastreamento da DAOP foi realizado atrav&#233;s do ITB, medido em repouso na posi&#231;&#227;o supina, com Doppler vascular port&#225;til (MEDPEJ DV-2001, 10 MHZ) e esfigmoman&#244;metro. O manguito foi selecionado com base na circunfer&#234;ncia braquial (CB) direita, medida no ponto m&#233;dio entre o acr&#244;mio e o ol&#233;crano: CB &lt; 25 cm (pequeno porte), CB 25-32 cm (m&#233;dio porte), CB 32-42 cm (grande porte) e CB &gt; 42 cm (coxa). Para padronizar a t&#233;cnica de medida do ITB, ao menos um pesquisador de cada centro (m&#233;dico e/ou enfermeira) foi treinado em oficinas de ITB, coordenadas pela autora principal. As press&#245;es sist&#243;licas foram medidas duas vezes em cada art&#233;ria, nos bra&#231;os (art&#233;rias braquiais) e tornozelos (art&#233;rias pediosas e tibiais posteriores). A press&#227;o registrada para cada art&#233;ria foi a m&#233;dia das duas medidas, desde que a diferen&#231;a entre elas fosse <underline>&lt;</underline> 6 mmHg; do contr&#225;rio, realizava-se outro par de medidas. Para o c&#225;lculo do ITB, utilizou-se a maior press&#227;o sist&#243;lica do tornozelo (pediosa m&#233;dia ou tibial posterior m&#233;dia) dividida pela maior press&#227;o dos bra&#231;os (braquial direita ou esquerda m&#233;dia), sendo calculado um valor de ITB para cada membro inferior<sup>11</sup>.</p>
    <p>Valores de ITB <underline>&lt;</underline> 0,90 em um ou em ambos os membros inferiores, foram considerados diagn&#243;sticos de DAOP. Aus&#234;ncia de DAOP foi definida como n&#237;veis de ITB de 0,91 a 1,40, na aus&#234;ncia de revasculariza&#231;&#227;o arterial de membros inferiores. Valores de ITB &gt; 1,40 foram exclu&#237;dos da an&#225;lise, pois n&#227;o definem o diagn&#243;stico de DAOP.</p>
    <p>
      <bold>Rastreamento de claudica&#231;&#227;o intermitente</bold>
    </p>
    <p>A presen&#231;a de claudica&#231;&#227;o intermitente foi definida pelos crit&#233;rios do Question&#225;rio de Claudica&#231;&#227;o de Edimburgo, validado para o portugu&#234;s<sup>12</sup>.</p>
    <p>
      <bold>Defini&#231;&#227;o de anormalidades dos pulsos dos tornozelos</bold>
    </p>
    <p>A palpa&#231;&#227;o dos pulsos dos tornozelos foi realizada nas art&#233;rias pediosas e tibiais posteriores, bilateralmente, e classificados em presentes ou ausentes.</p>
    <p>
      <bold>Exames laboratoriais</bold>
    </p>
    <p>Na segunda fase, ap&#243;s jejum, foram realizados exames capilares atrav&#233;s do uso de tecnologia <italic>point-of-care</italic> (Roche Diagnostics, Accu-Check) para an&#225;lise de glicemia capilar, colesterol total e triglic&#233;rides.</p>
    <p>
      <bold>An&#225;lise estat&#237;stica</bold>
    </p>
    <p>As estimativas de preval&#234;ncias foram calculadas com base em modelo de amostra complexa. A cada indiv&#237;duo foi designado um peso, de acordo com o sexo, cidade e regi&#227;o aos quais pertenciam. A associa&#231;&#227;o entre DAOP e cada vari&#225;vel foi determinada pelo teste Qui-Quadrado (X<sup>2</sup>) de Pearson, corrigido pelo plano amostral complexo. P <underline>&lt;</underline> 0,05 foram considerados indicadores de associa&#231;&#227;o significativa entre DAOP e a vari&#225;vel. A compara&#231;&#227;o das m&#233;dias das vari&#225;veis cont&#237;nuas foi realizada atrav&#233;s dos intervalos de confian&#231;a (IC), com base no plano amostral complexo. Na aus&#234;ncia de sobreposi&#231;&#227;o entre os IC, considerou-se que havia diferen&#231;a significativa.</p>
    <p>Construiu-se um modelo de regress&#227;o log&#237;stica multivari&#225;vel de acordo com a metodologia de Hosmer e Lemeshow<sup>13</sup>. Inicialmente realizaram-se an&#225;lises univari&#225;veis para obten&#231;&#227;o dos Odds Ratios (OR) brutos. A seguir, iniciou-se a an&#225;lise multivari&#225;vel incluindo-se as vari&#225;veis listadas (sexo, tabagismo, hipertens&#227;o, diabetes, idade, obesidade, colesterol e triglic&#233;rides) como poss&#237;veis preditoras de DAOP e vari&#225;veis s&#243;cio-demogr&#225;ficas, que poderiam impactar os fen&#244;menos relacionados &#224; sa&#250;de, tais como, renda familiar e escolaridade. As vari&#225;veis sexo, tabagismo, hipertens&#227;o, diabetes, idade e obesidade, foram categorizadas como 0 (ausente) ou 1 (presente) e as vari&#225;veis colesterol e triglic&#233;rides foram inclu&#237;das como vari&#225;veis cont&#237;nuas. Consideramos hipertenso indiv&#237;duos sabidamente hipertensos, em uso de medica&#231;&#227;o anti-hipertensiva ou com press&#227;o arterial no dia da visita acima de 140 x 90 mmHg; diab&#233;ticos, indiv&#237;duos sabidamente diab&#233;ticos, em uso de medica&#231;&#227;o hipoglicemiante ou com glicemia capilar acima de 126 mg/dL no dia da visita e hipercolesterol&#234;micos, indiv&#237;duos em uso de hipolipemiantes ou com colesterol total acima de 200 mg/dL no dia da visita.</p>
    <p>Nessa etapa, foram inclu&#237;das no modelo vari&#225;veis que apresentaram p &lt; 0,25. Devido a multicolinearidade entre renda e escolaridade, manteve-se apenas a vari&#225;vel escolaridade categorizada como: 0 (analfabeto), 1 (primeiro grau completo ou incompleto) e 2 (segundo grau ou n&#237;vel superior). Os dados foram analisados com os programas Stata (Release 9) e SPSS 13.0 for Windows (Statistical Package for Social Sciences), m&#243;dulo Complex Samples.</p>
    <p>No terceiro momento, foram inclu&#237;das as poss&#237;veis intera&#231;&#245;es com significado biol&#243;gico e/ou evid&#234;ncias de import&#226;ncia nas an&#225;lises das tabelas cruzadas, considerando-se p (entrada) &lt; 0,25. No modelo final, permaneceram as vari&#225;veis significativas a 5% ou aquelas que, mesmo n&#227;o significativas, eram vari&#225;veis de confundimento. Concluiu-se o processo de modelagem, ap&#243;s os testes de colinearidade e confundimento entre os fatores de risco a cada passo. O modelo estat&#237;stico de ajuste foi representado pela equa&#231;&#227;o:</p>
    <p>
      <graphic xlink:href="1678-4170-abc-91-06-0402-00008-e01.jpg"/></p>
    <p>onde &#946;i (i = 0,1,...,8) s&#227;o os coeficientes dos termos do modelo, x<sub>1</sub> = diabetes, x<sub>2</sub> = sexo, x<sub>3</sub> = doen&#231;a isqu&#234;mica do cora&#231;&#227;o (DIC), x<sub>4</sub> = hipertens&#227;o, x<sub>5</sub> = educa&#231;&#227;o superior. Os OR das vari&#225;veis n&#227;o presentes nas intera&#231;&#245;es foram obtidos pela exponencia&#231;&#227;o dos coeficientes &#946;. Quando h&#225; intera&#231;&#227;o entre um fator e outra vari&#225;vel, a estimativa do OR para o fator depende do valor da vari&#225;vel que est&#225; interagindo com ele.</p>
    <p> Nesta situa&#231;&#227;o, devido a impossibilidade de se estimar o OR pela simples exponencia&#231;&#227;o do coeficiente &#946;, utilizou-se as diferen&#231;as entre <italic>logits</italic>, definidas em fun&#231;&#227;o do modelo. Como os pacotes estat&#237;sticos n&#227;o possuem rotina para calcular OR e IC para intera&#231;&#245;es, eles foram calculados manualmente pela equipe com base na metodologia de Archer e Lemeshow<sup>14</sup>. O modelo final cont&#233;m as intera&#231;&#245;es Diabetes <italic>versus</italic> Sexo, DIC <italic>versus</italic> Sexo e Hipertens&#227;o <italic>versus</italic> Educa&#231;&#227;o superior. O ajustamento do modelo foi verificado pelo teste de Hosmer e Lemeshow, com o software Stata, utilizando um procedimento pr&#243;prio (Archer, K.J. &amp; Lemeshow S., 2006) desenvolvido para o referido teste em amostras complexas. Com esse procedimento foi obtido o valor: F<italic>-adjusted </italic> = 0,266 e p = 0,98.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>De um total de 1.170 indiv&#237;duos, 11 foram exclu&#237;dos devido a ITB &gt; 1,40 (0,85%), resultando em amostra final de 1.159. Houve predom&#237;nio de adultos jovens (53,6% com idade at&#233; 45 anos, 30,8% entre 45 e 59 anos e 15,6% com <underline>&gt;</underline> 60 anos) e a m&#233;dia de idade foi de 43,82 &#177; 14,68 anos (IC 95%: 43,02 &#150; 44,64), mulheres (53,3%) e ra&#231;a branca (Branca: 56,9%, Preta: 9,2%, Parda: 31,8%, Ind&#237;gena: 0,9% e outros: 1,3%). A maioria tinha o 1&#186; grau completo (Analfabetos: 2,4%, 1&#186; grau incompleto: 9,6%, 1&#186; grau completo: 45,0%, 2&#186; grau completo: 32,9% e Curso superior completo: 10,0%) e renda familiar de at&#233; 5 sal&#225;rios m&#237;nimos (SM) (<underline>&lt;</underline> 1 SM: 8,9%, de 1 a 5 SM: 54,3%, de 5 a 10 SM: 22,6% e &gt; 10 SM: 14,2%). A <xref ref-type="fig" rid="fig01">Figura 1</xref> mostra a distribui&#231;&#227;o dos participantes em rela&#231;&#227;o &#224;s regi&#245;es brasileiras.</p>
    <fig id="fig01">
      <graphic xlink:href="1678-4170-abc-91-06-0402-00008-gf01.jpg"/></fig>
    <p>A preval&#234;ncia de DAOP foi de 10,5% (n=134), distribu&#237;da da seguinte forma nas Regi&#245;es brasileiras: Norte/centro-oeste=17,8% (n=22/119), Sul=12,0% (24/199), Sudeste=11,7% (76/592), Nordeste=4,6% (12/173). N&#227;o houve diferen&#231;a significativa na preval&#234;ncia entre as regi&#245;es (p=0,35).</p>
    <p>
      <bold>An&#225;lise univariada</bold>
    </p>
    <p>As compara&#231;&#245;es entre os grupos com e sem DAOP em rela&#231;&#227;o &#224;s caracter&#237;sticas s&#243;cio-demogr&#225;ficas, aos h&#225;bitos de vida, &#224;s condi&#231;&#245;es cl&#237;nicas coexistentes, ao uso de medicamentos, &#224; presen&#231;a de sintomas, exame dos pulsos e exames laboratoriais est&#227;o apresentadas nas <xref ref-type="table" rid="tab01">Tabelas 1</xref>, <xref ref-type="table" rid="tab02">2</xref>, <xref ref-type="table" rid="tab03">3</xref>, e <xref ref-type="fn" rid="tab04">4</xref>, respectivamente.</p>
    <table-wrap id="tab01">
      <graphic xlink:href="1678-4170-abc-91-06-0402-00008-gt01.jpg"/></table-wrap>
    <table-wrap id="tab02">
      <graphic xlink:href="1678-4170-abc-91-06-0402-00008-gt02.jpg"/></table-wrap>
    <table-wrap id="tab03">
      <graphic xlink:href="1678-4170-abc-91-06-0402-00008-gt03.jpg"/></table-wrap>
    <p>
      <fn id="tab04">
        <p>
          <graphic xlink:href="1678-4170-abc-91-06-0402-00008-e02.jpg"/></p>
      </fn>
    </p>
    <p>
      <bold>Regress&#227;o log&#237;stica multivari&#225;vel</bold>
    </p>
    <p>Para analisar a intera&#231;&#227;o DIC <italic>versus</italic> Sexo foram estimados os OR de DIC dentro de cada sexo (<xref ref-type="table" rid="tab05">Tabela 5</xref>). O valor do OR para DIC presente, para o sexo masculino foi de 1,21 (0,44; 3,31), n&#227;o significativo, enquanto para o sexo feminino foi de 4,92 (2,52; 9,59), altamente significativo, evidenciando a intera&#231;&#227;o. A an&#225;lise da intera&#231;&#227;o Diabetes <italic>versus</italic> Sexo mostra que o efeito de diabetes em indiv&#237;duos do sexo masculino foi altamente significativo, OR = 6,65 (2,6; 17,01). Para o sexo feminino esse risco n&#227;o foi significativo, OR = 1,19 (0,55; 2,57) (<xref ref-type="fig" rid="grf01">Gr&#225;fico 1</xref>).</p>
    <table-wrap id="tab05">
      <graphic xlink:href="1678-4170-abc-91-06-0402-00008-gt04.jpg"/></table-wrap>
    <fig id="grf01">
      <graphic xlink:href="1678-4170-abc-91-06-0402-00008-gf02.jpg"/></fig>
    <p>A performance discriminat&#243;ria do modelo foi validada pelo &#237;ndice-C que corresponde &#224; &#225;rea sob a curva ROC (Receiver Operation Curve). Foi obtida a &#225;rea = 0,621 IC95% (0,568; 0,675).</p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>O Projeto Cora&#231;&#245;es do Brasil &#233; um estudo epidemiol&#243;gico sobre a preval&#234;ncia dos fatores de risco cardiovascular em amostra populacional aleat&#243;ria, proveniente de 72 centros urbanos brasileiros. Foi avaliada uma amostragem populacional com idade <underline>&gt;</underline> 18 anos, residente em cidades com mais de cem mil habitantes. Esse projeto foi o pioneiro no Brasil ao avaliar de forma objetiva a preval&#234;ncia de DAOP, tanto sintom&#225;tica quanto assintom&#225;tica, por meio da mensura&#231;&#227;o do ITB e do question&#225;rio de claudica&#231;&#227;o de Edimburgo<sup>12</sup>.</p>
    <p>A preval&#234;ncia de DAOP foi de 10,5%, inferindo-se aproximadamente 6 milh&#245;es de indiv&#237;duos, levando-se em conta que, no Brasil, existem 57 milh&#245;es de habitantes com as caracter&#237;sticas da popula&#231;&#227;o avaliada neste estudo (dados obtidos atrav&#233;s do IBGE).</p>
    <p>A m&#233;dia de idade foi mais elevada nos portadores de DAOP em compara&#231;&#227;o aos indiv&#237;duos sem a doen&#231;a (49,02 anos x 44,23 anos, p=0,049). Houve tend&#234;ncia de associa&#231;&#227;o entre DAOP e faixa et&#225;ria (p=0,08), com preval&#234;ncia crescente da doen&#231;a &#224; medida que a faixa et&#225;ria aumentava. O pequeno n&#250;mero de indiv&#237;duos na faixa et&#225;ria acima de 60 anos, - uma vez que o estudo n&#227;o foi desenhado especificamente para avaliar a preval&#234;ncia de DAOP, mas para avaliar os diversos fatores de risco e ser representativo da popula&#231;&#227;o brasileira - e a ampla margem de faixas et&#225;rias deste estudo (43,82 &#177; 14,68), podem ter reduzido o poder da amostra em detectar tal associa&#231;&#227;o no valor de p &lt; 0,05.</p>
    <p>Entretanto, o valor de p obtido indica consistente tend&#234;ncia de que a associa&#231;&#227;o entre DAOP e faixa et&#225;ria tenha realmente existido. Estudos que avaliaram especificamente idosos (<underline>&gt;</underline> 65 anos), relataram preval&#234;ncia entre 7% e 36%<sup>9,15-18</sup>, enquanto que em popula&#231;&#245;es mais jovens como a do presente estudo, a preval&#234;ncia variou de 3% a 16%<sup>19-24</sup>. Nas popula&#231;&#245;es de alto risco cardiovascular, ela variou entre 29% e 40,5%<sup>25,26</sup>.</p>
    <p>No presente estudo, houve maior preval&#234;ncia de DAOP entre as mulheres &#224; semelhan&#231;a de outros estudos publicados<sup>9,20,21,27</sup>, embora freq&#252;entemente se relate maior preval&#234;ncia entre os homens<sup>16,17,22,23</sup>. No estudo GetABI, nas faixas et&#225;rias mais jovens (65-74 anos), a preval&#234;ncia foi maior entre homens e, nas faixas et&#225;rias mais avan&#231;adas (<underline>&gt;</underline> 75 anos), maior entre as mulheres<sup>16</sup>.</p>
    <p>Observou-se tend&#234;ncia a maior preval&#234;ncia de DAOP entre aqueles que n&#227;o praticavam atividade f&#237;sica (p=0,08). O sedentarismo pode ser visto tanto como fator de risco para o desenvolvimento da DAOP, quanto como reflexo do comprometimento funcional dos membros inferiores provocado pela doen&#231;a<sup>28</sup>. A preval&#234;ncia de DAOP foi o dobro entre os indiv&#237;duos que fumaram &gt; 20 anos/ma&#231;o em rela&#231;&#227;o aos que fumaram menor quantidade de cigarros. Dado semelhante foi relatado no Estudo GetABI (34,5% e 19,5% entre os que fumaram mais de 20 anos/ma&#231;o e menos de 20 anos/ma&#231;o respectivamente)<sup>16</sup>. N&#227;o houve associa&#231;&#227;o entre consumo de &#225;lcool e DAOP. No Estudo de Rotterdam, observou-se associa&#231;&#227;o inversa entre o consumo de &#225;lcool e DAOP, apenas em indiv&#237;duos n&#227;o fumantes<sup>29</sup>.</p>
    <p> Os portadores de DAOP apresentaram o triplo da preval&#234;ncia de AVC e o dobro da preval&#234;ncia de DIC, manifesta por angina pectoris e/ou infarto do mioc&#225;rdio, em compara&#231;&#227;o com o grupo sem DAOP. A coexist&#234;ncia de DAOP e les&#245;es ateroscler&#243;ticas em outros leitos vasculares tem sido relatada, especialmente entre os idosos. Em um desses estudos, na presen&#231;a de DAOP, a preval&#234;ncia de DIC foi de 68% e de AVC, 42%<sup>30</sup>.</p>
    <p>Houve tend&#234;ncia a maior preval&#234;ncia de hipertens&#227;o arterial, IRC dial&#237;tica e insufici&#234;ncia card&#237;aca no grupo com DAOP. V&#225;rios estudos j&#225; relataram tais associa&#231;&#245;es. No Estudo SHEP (<italic>Systolic Hypertension in the Elderly Program</italic>), a preval&#234;ncia de DAOP entre hipertensos foi de 27%<sup>31</sup>. Entre portadores de IRC avan&#231;ada, a preval&#234;ncia da doen&#231;a variou de 17 a 48%<sup>32 </sup>e no <italic>Cardiovascular Health Study, </italic>a presen&#231;a de DAOP foi preditora independente da ocorr&#234;ncia de insufici&#234;ncia card&#237;aca (RR = 1,61)<sup>33</sup>.</p>
    <p>Em rela&#231;&#227;o &#224; dislipidemia, n&#227;o houve associa&#231;&#227;o entre DAOP e dislipidemia referida, nem foi observada diferen&#231;a significativa nos n&#237;veis m&#233;dios de colesterol e triglic&#233;rides entre os grupos. O uso de hipolipemiantes foi similar nos grupos com e sem DAOP e n&#227;o deve ter contribu&#237;do para a falta de associa&#231;&#227;o entre as vari&#225;veis. No Estudo GetABI, a for&#231;a de associa&#231;&#227;o entre par&#226;metros lip&#237;dicos e DAOP foi considerada limitada, em compara&#231;&#227;o aos demais fatores de risco cardiovasculares<sup>34</sup>. Chama a aten&#231;&#227;o que embora 24,6% dos portadores de DAOP referissem dislipidemia, apenas 4,5% estava em uso de hipolipemiantes.</p>
    <p>A preval&#234;ncia de diabete, entre portadores de DAOP, foi 2,7 vezes maior em compara&#231;&#227;o ao grupo sem DAOP. Os n&#237;veis de glicemia foram discretamente mais elevados no grupo com DAOP, por&#233;m sem signific&#226;ncia estat&#237;stica. A diabete &#233; um importante fator de risco para o desenvolvimento de DAOP. Estudos que utilizaram o ITB para rastrear DAOP entre diab&#233;ticos demonstram preval&#234;ncia da doen&#231;a entre 20 e 29%<sup>26,35</sup>.</p>
    <p>A obesidade foi avaliada neste estudo com base nas medidas do &#237;ndice de massa corporal (IMC), circunfer&#234;ncia abdominal (CA) e rela&#231;&#227;o cintura-quadril (RCQ). Tanto o IMC <underline>&gt;</underline> 30 quanto a RCQ aumentada estiveram associados &#224; DAOP, sendo a associa&#231;&#227;o entre RCQ e DAOP mais expressiva entre as mulheres. N&#227;o houve associa&#231;&#227;o entre a medida da CA e DAOP. Alguns estudos mostraram associa&#231;&#227;o de DAOP com obesidade abdominal mas n&#227;o com o IMC, enquanto outros mostraram associa&#231;&#227;o de DAOP com obesidade total e abdominal apenas entre as mulheres<sup>36,37</sup>.</p>
    <p>A preval&#234;ncia de claudica&#231;&#227;o intermitente foi de 7%. Na literatura, a preval&#234;ncia varia de 0,4 a 14%, na depend&#234;ncia da idade, sexo, perfil de risco e m&#233;todo diagn&#243;stico utilizado<sup>2</sup>. Dentre os portadores de DAOP a preval&#234;ncia de claudica&#231;&#227;o foi de apenas 9% e sua presen&#231;a n&#227;o esteve associada &#224; DAOP. Em um estudo que avaliou diferentes grupos &#233;tnicos, a preval&#234;ncia de claudica&#231;&#227;o foi de 7,5%<sup>38</sup>. Como a maioria dos portadores de DAOP &#233; assintom&#225;tica ou apresenta sintomas inespec&#237;ficos, os question&#225;rios de claudica&#231;&#227;o, &#250;teis para identificar pacientes sintom&#225;ticos, n&#227;o servem para rastreamento da DAOP, o que refor&#231;a o papel da medida do ITB na avalia&#231;&#227;o de popula&#231;&#245;es de risco para ocorr&#234;ncia da doen&#231;a.</p>
    <p>&#201; importante ressaltar a associa&#231;&#227;o entre a presen&#231;a de dor ou desconforto na (s) perna(s) durante a caminhada e DAOP, mesmo quando os crit&#233;rios para claudica&#231;&#227;o n&#227;o foram preenchidos, j&#225; que tal queixa foi relatada por mais da metade dos portadores de DAOP, o que sugere que sua presen&#231;a deve ser valorizada na avalia&#231;&#227;o cl&#237;nica desses pacientes. Tal achado j&#225; havia sido descrito por nosso grupo, em idosos participantes do estudo Epidoso<sup>9</sup>.</p>
    <p>A aus&#234;ncia dos pulsos dos tornozelos &#224; palpa&#231;&#227;o, especialmente dos tibiais posteriores, esteve associada &#224; DAOP. As anormalidades dos pulsos tibiais posteriores s&#227;o mais sens&#237;veis e espec&#237;ficas para a presen&#231;a de DAOP do que as anormalidades dos pediosos, j&#225; que cerca de 10% da popula&#231;&#227;o saud&#225;vel n&#227;o apresenta esses pulsos palp&#225;veis<sup>39</sup>.</p>
    <p>Ao se analisar a intera&#231;&#227;o entre g&#234;nero e as condi&#231;&#245;es cl&#237;nicas coexistentes, observou-se que as mulheres com DIC inclu&#237;das no estudo Cora&#231;&#245;es do Brasil apresentaram risco cerca de 5 vezes maior de ter DAOP do que aquelas sem DIC, enquanto que nos homens diab&#233;ticos o risco de apresentar DAOP foi 6,6 vezes em compara&#231;&#227;o aos n&#227;o diab&#233;ticos. Uma poss&#237;vel explica&#231;&#227;o, no caso das mulheres, seria a tend&#234;ncia de desenvolver doen&#231;a cardiovascular mais tardiamente, devido ao fator de prote&#231;&#227;o hormonal. A p&#243;s-menopausa poderia elevar a chance de manifesta&#231;&#245;es de acometimento vascular em mais de um territ&#243;rio. Por outro lado, sexo masculino e diabetes s&#227;o dois fatores que t&#234;m estado associados &#224; manifesta&#231;&#227;o de DAOP em faixas et&#225;rias mais jovens<sup>16</sup>.</p>
    <p>
      <bold>Implica&#231;&#245;es cl&#237;nicas</bold>
    </p>
    <p>Os dados do Projeto Cora&#231;&#245;es do Brasil lan&#231;am um alerta para a comunidade m&#233;dica brasileira sobre a necessidade do rastreamento da DAOP na pr&#225;tica cl&#237;nica. Esse alerta se baseia n&#227;o apenas na elevada preval&#234;ncia de DAOP encontrada no estudo mas, principalmente, no expressivo contingente de portadores assintom&#225;ticos (91%) que, detectados precocemente, poderiam se beneficiar das medidas preventivas para redu&#231;&#227;o do risco de infarto agudo do mioc&#225;rdio, acidente vascular cerebral e morte cardiovascular. A simples ado&#231;&#227;o da medida do ITB, como parte da avalia&#231;&#227;o de pacientes de moderado e alto risco cardiovascular, implicaria em substancial impacto sobre a detec&#231;&#227;o precoce dos portadores assintom&#225;ticos da doen&#231;a.</p>
    <p>
      <bold>Limita&#231;&#245;es</bold>
    </p>
    <p>Esse estudo n&#227;o foi desenhado com o intuito de estimar a preval&#234;ncia de DAOP ao n&#237;vel de cidades, j&#225; que em algumas delas a amostra foi constitu&#237;da de apenas 15 indiv&#237;duos, mas sim ao n&#237;vel de regi&#245;es. Sua principal limita&#231;&#227;o &#233; n&#227;o ter tido poder amostral suficiente para ser representativo da popula&#231;&#227;o brasileira como um todo. Seu poder &#233; suficiente para representar a popula&#231;&#227;o brasileira de centros urbanos com mais de cem mil habitantes, estimada em 57 milh&#245;es. Uma limita&#231;&#227;o de car&#225;ter secund&#225;rio foi a exclus&#227;o de cidades como Mar&#237;lia, Petr&#243;polis e Santa Maria da an&#225;lise da vari&#225;vel <italic>tempo m&#233;dio de dura&#231;&#227;o das atividades f&#237;sicas</italic>, pelo delineamento amostral, com base no n&#250;mero <italic>insuficiente</italic> de indiv&#237;duos v&#225;lidos na amostra.</p>
    <p>
      <bold>Agradecimentos</bold>
    </p>
    <p>&#192; Diretoria da Sociedade Brasileira de Cardiologia (SBC) &#150; Bi&#234;nio 2004/2005, na pessoa de seu Presidente Dr. Ant&#244;nio Felipe Sim&#227;o. Aos M&#233;dicos s&#243;cios da SBC, enfermeiras, estudantes de medicina e enfermagem, t&#233;cnicos de enfermagem e t&#233;cnicos de laborat&#243;rio que participaram voluntariamente da 2&#170;. Etapa do estudo. Aos patrocinadores, capacitadores, investigadores e coordenadores de campo do Projeto Cora&#231;&#245;es do Brasil, listados no <xref ref-type="app" rid="ape">ap&#234;ndice</xref> dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://www.arquivosonline.com.br/2008/">http://www.arquivosonline.com.br/2008/</ext-link></p>
    <p>Aos estat&#237;sticos Elsa Cristina de Mundstock, MSc, Jandyra Maria Guimar&#227;es Fachel, PhD, e Vinicius Nunes Machado, Bacharel em Estat&#237;stica.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>Este estudo foi realizado com dados obtidos no Projeto Cora&#231;&#245;es do Brasil, sendo que o Fator de Risco Doen&#231;a Arterial Perif&#233;rica contou com patroc&#237;nio institucional da Empresa Libbs Farmac&#234;utica.</p>
    <p>O Projeto Cora&#231;&#245;es do Brasil tamb&#233;m contou com os patroc&#237;nios institucionais das seguintes Empresas: AstraZeneca, Biosint&#233;tica, Biolab, Novartis, Sanofi-Aventis, Omron, Roche Diagn&#243;sticos, Centrais El&#233;tricas Furnas, Minist&#233;rio da Sa&#250;de e pelo Conselho Nacional de Secret&#225;rios Municipais de Sa&#250;de (Conasems)</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>N&#227;o h&#225; vincula&#231;&#227;o deste estudo a programas de p&#243;s-gradua&#231;&#227;o.</p>
    <p>
      <fn id="end" fn-type="corresp">
        <label>
          <bold>Correspond&#234;ncia:</bold>
        </label>
        <p> Marcia Makdisse </p>
        <p> Rua Dr. Franco da Rocha 205 / 51, Perdizes </p>
        <p> 05015-040 - S&#227;o Paulo, SP, Brasil. </p>
        <p> E-mail: </p>
        <p><email xlink:href="mmakdisse@einstein.br">mmakdisse@einstein.br</email>, </p>
        <p><email xlink:href="mmakdisse@yahoo.com">mmakdisse@yahoo.com</email>, </p>
        <p>
          <email xlink:href="mmakdisse@cardiol.br">mmakdisse@cardiol.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 30/06/08; revisado recebido em 06/08/08; aceito em 15/08/08.</p>
    <p/>
    <p>Este estudo foi realizado com dados obtidos no Projeto Cora&#231;&#245;es do Brasil, sendo que o Fator de Risco Doen&#231;a Arterial Perif&#233;rica contou com patroc&#237;nio institucional da Empresa Libbs Farmac&#234;utica.</p>
    <p>O Projeto Cora&#231;&#245;es do Brasil tamb&#233;m contou com os patroc&#237;nios institucionais das seguintes Empresas: AstraZeneca, Biosint&#233;tica, Biolab, Novartis, Sanofi-Aventis, Omron, Roche Diagn&#243;sticos, Centrais El&#233;tricas Furnas, Minist&#233;rio da Sa&#250;de e pelo Conselho Nacional de Secret&#225;rios Municipais de Sa&#250;de (Conasems)</p>
    <p>Capacitadores:</p>
    <p><bold>1)</bold> Dra. Elizabete Viana de Freitas (Presidente do Depto. de Cardiogeriatria / SBC);</p>
    <p><bold>2)</bold> Dr. Alexandre da Costa Pereira (Instituto do Cora&#231;&#227;o da Faculdade de Medicina da Universidade de S&#227;o Paulo- InCor-USP);</p>
    <p><bold>3)</bold> Dra. Alexandra Alberta dos Santos (Unifesp);</p>
    <p><bold>4)</bold> Dr. Anderson Rodrigues de Oliveira (Universidade Federal de S&#227;o Paulo &#150; Unifesp);</p>
    <p><bold>5)</bold> Dr. Antonio Carlos Palandri Chagas (Presidente da SBC);</p>
    <p><bold>6)</bold> Dr. &#193;lvaro Avezum Junior (Presidente Passado - SBC/FUNCOR);</p>
    <p><bold>7)</bold> Dra. Maria Elizabeth Navegantes Caetano Costa (Pres. do Depto. de Cardiopatia e Gravidez / SBC); </p>
    <p><bold>8)</bold> Dr. David de P&#225;dua Brasil (Faculdade de Ci&#234;ncias M&#233;dicas de MG);</p>
    <p><bold>9)</bold> Dr. Eduardo Papa (Unifesp); </p>
    <p><bold>10)</bold> Dr. F&#225;bio Rocha Farias (Unifesp);</p>
    <p><bold>11)</bold> Dr. F&#225;bio Zanerato (Unifesp);</p>
    <p><bold>12)</bold> Dr. Andrei Carvalho Sposito (Presidente do Depto de Aterosclerose/SBC);</p>
    <p><bold>13)</bold> Dr. George Luiz Lins Machado Coelho (Universidade Federal de Ouro Preto);</p>
    <p><bold>14)</bold> Dr. Jairo Lins Borges (Instituto de Cardiologia Dante Pazzanese);</p>
    <p><bold>15) </bold>Dr. Jos&#233; Carlos Sim&#245;es (Unifesp);</p>
    <p><bold>16)</bold> Dr. Jos&#233; Eduardo Krieger (InCor-USP);</p>
    <p><bold>17)</bold> Dr. Jorge Ilha Guimar&#227;es (Presidente Futuro da SBC)</p>
    <p><bold>18)</bold> Dra. Luc&#233;lia Magalh&#227;es (Universidade Federal da Bahia);</p>
    <p><bold>19)</bold> Dr. Manes Erlichman (Unifesp);</p>
    <p><bold>20)</bold> Dra. Marcia Makdisse (Hospital Israelita Albert Einstein/Unifesp);</p>
    <p><bold>21)</bold> Dr. Ari Timerman (Presidente da SOCESP).</p>
    <p>Investigadores e coordenadores de campo</p>
    <p><bold>1) Alagoas -</bold> Macei&#243;: Investigador(a): Dr. Marco Ant&#244;nio Mota Gomes, Coordenador(a) de Campo: Maril&#250;cia Mota de Moraes;</p>
    <p><bold>2) Amazonas -</bold> Manaus: Investigador(a): Dra. Maria Christina Cavalcanti Ballut, Coordenador(a) de Campo: Anderson da Silva Terrazas;</p>
    <p><bold>3) Bahia - </bold>Feira de Santana: Investigador(a): Dra. Id&#225;lia Vieira Azevedo Silva, Coordenador(a) de Campo: Leonor da Silva Bastos;</p>
    <p><bold>Salvador -</bold> Investigador(a): Dr. M&#225;rio de Seixas Rocha, Coordenador(a) de Campo: Maria Tereza Esteves Brito Costa;</p>
    <p><bold>4) Cear&#225; -</bold> Fortaleza: Investigador(a): Dr. Jos&#233; Maria Bonfim de Morais, Coordenador(a) de Campo: Sandra Solange Leite Campos;</p>
    <p><bold>5) Distrito Federal - Bras&#237;lia e Taguatinga:</bold> Investigador(a): Dr. Geniberto Paiva Campos, Coordenadores de Campo: Romero Bezerra Barbosa e Rosa Nancy Urribari Runzer Sallenave;</p>
    <p><bold>6) Esp&#237;rito Santo - Vila Velha: </bold>Investigador(a): Dr. Ant&#244;nio Carlos Avanza J&#250;nior, Coordenador(a) de Campo: Fernanda Almeida Tarden;</p>
    <p><bold>Vit&#243;ria:</bold> Investigador(a): Dr. Ant&#244;nio Carlos Avanza J&#250;nior, Coordenador(a) de Campo: Fernanda Motta Del Caro;</p>
    <p><bold>7) Goi&#225;s - An&#225;polis: </bold>Investigador(a): Dr. Ricardo Nogueira de Paiva, Coordenador(a) de Campo: Rosana Mendes Bezerra;</p>
    <p><bold> Goi&#226;nia:</bold> Investigador(a): Dr. Weimar Kunz Sebba Barroso de Souza, Coordenador(a) de Campo: Priscila Valverde de Oliveira Vitorino;</p>
    <p><bold>Urua&#231;u:</bold> Investigador(a): Dr. Oswaldo Barroso de Souza Filho;</p>
    <p><bold>8) Maranh&#227;o - S&#227;o Luis: </bold>Investigador(a): Dr. Jos&#233; Benedito Buhatem, Coordenador(a) de Campo: Rachel Jorge Dino Cosseti;</p>
    <p><bold>9) Mato Grosso - Cuiab&#225;: </bold>Investigador(a): Dra. Marta de Medeiros Neder, Coordenador(a) de Campo: Luzia Helena Franco Carvalho Moya;</p>
    <p><bold>10) Mato Grosso Do Sul </bold>- <bold>Campo Grande: </bold>Investigador(a): Dr. Ricardo Ayache, Coordenador(a) de Campo: Rose Mary Uehara;</p>
    <p><bold>11) Minas Gerais - Alfenas:</bold> Investigador(a): Dr. Giovanni Guarda Garcia, Coordenador(a) de Campo: Lucas Bellusci Paolucci Amorim;</p>
    <p><bold>Barbacena:</bold> Investigador(a): Dr. Jos&#233; Gabriel Guimar&#227;es, Coordenador(a) de Campo: Edivaldo Jos&#233; de Souza;</p>
    <p><bold>Belo Horizonte:</bold> Investigador(a): Dr. Raimundo M. do Nascimento Neto, Coordenadores de Campo: Bernardo Luiz Fornaciari Ramos, Eduardo Viana Lobato, Guilherme Cardoso Parreiras e Tiago Dam&#225;zio Godoy de Abreu;</p>
    <p><bold>Divin&#243;polis:</bold> Investigador(a): Dr. Otaviano Jos&#233; Greco Rodrigues, Coordenador(a) de Campo: Maria In&#234;s Ribeiro Le&#227;o;</p>
    <p><bold>Governador Valadares:</bold> Investigador(a): Dr. Guilherme Gustavo do Valle, Coordenador(a) de Campo: Eliene Nascimento Boneares;</p>
    <p><bold>Ipatinga:</bold> Investigador(a): Dr. Hamilton Jos&#233; Gon&#231;alves, Coordenador(a) de Campo: Gilda Gr&#233;cia Gon&#231;alves;</p>
    <p><bold>Juiz de Fora: </bold>Investigador(a): Dr. Wilson Coelho Pereira Filho, Coordenador(a) de Campo: Marcos Cardoso Benhami; Montes Claros: Investigador(a): Dr. Ev&#226;nio Rodrigues Cordeiro, Coordenador(a) de Campo: Daniela Oliveira Lima;</p>
    <p><bold>Po&#231;os de Caldas:</bold> Investigador(a): Dr. Jos&#233; Tasca;</p>
    <p><bold>Pouso Alegre:</bold> Investigador(a): Dra. Nadja Sotero Natividade Mendes, Coordenador(a) de Campo: Cristiane Maciel Zambolim;</p>
    <p><bold>Uberaba:</bold> Investigador(a): Dr. Luiz Ant&#244;nio P. R. de Resende, Coordenador(a) de Campo: Rodrigo Gimenez Pissutti Modolo;</p>
    <p><bold>Uberl&#226;ndia:</bold> Investigador(a): Dr. Elmiro Santos Resende, Coordenador(a) de Campo: Eduardo Moreira dos Santos;</p>
    <p><bold>Varginha:</bold> Investigador(a): Dr. Armando Martins Pinto, Coordenador(a) de Campo: Fernanda Curry Carneiro Pinto;</p>
    <p><bold>12) Par&#225; - Bel&#233;m:</bold> Investigador(a): Dra. Sonia Conde Cristino, Coordenador(a) de Campo: Rosa Helena Ribeiro Castro;</p>
    <p><bold>13) Para&#237;ba - Campina Grande: </bold>Investigador(a): Dr. Miguel Pereira Ribeiro, Coordenador(a) de Campo: Ademilda M. G. S. Garcia de Campo;</p>
    <p><bold>Jo&#227;o Pessoa:</bold> Investigador(a): Dr. Jo&#227;o Cavalcanti A. Filho, Coordenador(a) de Campo: Jusara Gabriel Ramos da Costa;</p>
    <p><bold>14) Paran&#225; </bold>-<bold> Cascavel:</bold> Investigador(a): Dr. Walter de Assump&#231;&#227;o, Coordenador(a) de Campo: Mauricio Figueiredo Lima e Marchese;</p>
    <p><bold>Curitiba:</bold> Investigador(a): Dr. Dalton Bertolim Precoma, Coordenador(a) de Campo: Tha&#237;s Har&#233;n Rufino;</p>
    <p><bold>Foz do Igua&#231;&#250;:</bold> Investigador(a): Dr. Odilon Sehn, Coordenador(a) de Campo: Vera L&#250;cia Gomes; Londrina: Investigador(a): Dr. Wellington Ant&#244;nio Moreira da Silva, Coordenador(a) de Campo: Paulo M&#252;ller Ramos,</p>
    <p><bold>Maring&#225;:</bold> Investigador(a): Dr. M&#225;rio Lins Peixoto, Coordenador(a) de Campo: L&#237;dia Cristina Troca;</p>
    <p><bold>15) Pernambuco: Recife:</bold> Investigador (a): Dra. Silvana Maria Daconti; Coordenador(a) de Campo: Carlos Eduardo Lucena Montenegro;</p>
    <p><bold>16) Piau&#237;: Teresina:</bold> Investigador(a): Dr. Jos&#233; Carlos Formiga L. de Sousa, Coordenador(a) de Campo: Luc&#237;ola Galv&#227;o Gondim Corr&#234;a Feitosa;</p>
    <p><bold>17) Rio de Janeiro - Campos dos Goytacazes:</bold> Investigador(a): Dr. Jamil da Silva Soares, Coordenador(a) de Campo: Leandro Cordeiro Soares;</p>
    <p><bold>Niter&#243;i:</bold> Investigador(a): Dr. Ant&#244;nio Alves Couto, Coordenador(a) de Campo: Annelise Cisari Constanza; </p>
    <p><bold>Nova Igua&#231;u:</bold> Investigador(a): Dra. S&#244;nia Regina Reis Zimbaro, Coordenador(a) de Campo: Maria da Guia de Souza;</p>
    <p><bold>Petr&#243;polis:</bold> Investigador(a): Nome: Dr. Jos&#233; Osman Gomes Aguiar, Coordenador(a) de Campo: Miguel Osman Dias Aguiar;</p>
    <p><bold>Rio de Janeiro:</bold> Investigador(a): Dr. Rafael Arow Abitbol, Coordenadores de Campo: Danielle Reis de Almeida e M&#244;nica Carla dos Santos Sobreira;</p>
    <p><bold>S&#227;o Gon&#231;alo:</bold> Investigador(a): Dr. Adalberto Oliveira, Coordenador(a) de Campo: Cl&#225;udia M&#225;rcia Cabral Feij&#243; Oliveira;</p>
    <p><bold>Volta Redonda:</bold> Investigador(a): Dr. Jair Nogueira Filho, Coordenador(a) de Campo: Tatiana Cunha de Paiva;</p>
    <p><bold>18) Rio Grande do Norte - Natal:</bold> Investigador(a): Dra. Maria F&#225;tima de Azevedo, Coordenador(a) de Campo: F&#225;bio Gerson S&#225; Gabriel da Silva;</p>
    <p><bold>19) Rio Grande do Sul - Canoas:</bold> Investigador(a): Dr. Ilmar Kohler, Coordenador(a) de Campo: Sandra Maria Borges; </p>
    <p><bold>Caxias do Sul:</bold> Investigador(a): Dr. F&#225;bio Allgayer, Coordenador(a) de Campo: Marciane Andr&#233;ia Maschio;</p>
    <p><bold>Novo Hamburgo:</bold> Investigador(a): Dr. Leandro E. Roese, Coordenador(a) de Campo: Cl&#225;udia Zuquetto;</p>
    <p><bold>Pelotas:</bold> Investigador(a): Dr. Andr&#233; Avelino Steffens, Coordenador(a) de Campo: Katiuscia Milano Rosales;</p>
    <p><bold>Porto Alegre:</bold> Investigador(a): Dra. Leila Beltrami Moreira, Coordenador(a) de Campo: Ricardo Flores da Costa; </p>
    <p><bold>Santa Maria:</bold> Investigador(a): Dr. Alexandre Antonio Naujorks, Coordenador(a) de Campo: Simone Kroll Rabelo; </p>
    <p><bold>20) Santa Catarina - Blumenau:</bold> Investigador(a): Dr. Siegmar Starke, Coordenador(a) de Campo: Daniela Moser Carlini;</p>
    <p><bold>Florian&#243;polis:</bold> Investigador(a): Dr. Miguel de Patta, Coordenador(a) de Campo: Dulcin&#233;ia Ghizoni Schneider;</p>
    <p><bold>Joinville:</bold> Investigador(a): Dr. Carlos Roberto Campos, Coordenador(a) de Campo: Niuc&#233;ia Lari Schor Krelling;</p>
    <p><bold>21) S&#227;o Paulo - Araras: </bold>Investigador(a): Dr. Agnaldo P&#237;spico, Coordenador(a) de Campo: Alexandre Franco Garcia;</p>
    <p><bold>Bauru:</bold> Investigador(a): Dr. Andr&#233; Saab, Coordenador(a) de Campo: Fabiana Cristina do Nascimento; </p>
    <p><bold>Campinas:</bold> Investigador(a): Dr. Jos&#233; Francisco Kerr Saraiva, Coordenador(a) de Campo: Larissa Lopes de Assis Balsani;</p>
    <p><bold>Franca:</bold> Investigador(a): Dr. Ulisses M&#225;quez Gianecchini, Coordenador(a) de Campo: Cyntia Kall&#225;s Bachur;</p>
    <p><bold>Jundia&#237;:</bold> Investigador(a): Wagner Tadeu Ligab&#243;; Coordenador(a) de Campo: Louren&#231;o Texeira Ligab&#243;; Mar&#237;lia: Investigador(a): Dr. Ricardo Jos&#233; Tofano, Coordenador(a) de Campo: Sueli Hissami Higute Ajeka;</p>
    <p><bold>Mogi das Cruzes:</bold> Investigador(a): Dr. Marcos Sleiman Molina,</p>
    <p><bold>Piracicaba:</bold> Investigador(a): Dra. Celise Alessandra Sobral Denardi, Coordenador(a) de Campo: Maria &#194;ngela Ad&#226;moli M. Rossetto;</p>
    <p><bold>Presidente Prudente:</bold> Investigador(a): Dr. Luiz Carlos Pontes, Coordenador(a) de Campo: Silvana Maria Furlanetto Tiezzi Pontes;</p>
    <p><bold>Ribeir&#227;o Preto:</bold> Investigador(a): Dr. D&#233;cio de Lima Pinho, Coordenador(a) de Campo: Eug&#234;nia Veludo Veiga;</p>
    <p><bold>Santo Andr&#233; / S&#227;o Bernardo / S&#227;o Caetano:</bold> Investigador(a): Dra. Carla Janice Lantieri Merten, Coordenador(a) de Campo: Marisa Beraldo;</p>
    <p><bold>Santos:</bold> Investigador(a): Dr. Hermes T&#243;ros Xavier; Coordenador(a) de Campo: Lucas Pedroso Fernandes Ferreira Leal;</p>
    <p><bold>S&#227;o Jos&#233; do Rio Preto:</bold> Investigador(a): Dr. Jos&#233; Carlos Aidar Ayoub, Coordenador(a) de Campo: Camila Vigano Zanoti;</p>
    <p><bold>S&#227;o Jos&#233; dos Campos:</bold> Investigador(a): Dr. Carlos Costa Magalh&#227;es, Coordenador(a) de Campo: Maria Cec&#237;lia M. Pires Hirga;</p>
    <p><bold>S&#227;o Paulo:</bold> Investigador(a): Dr. Carlos Alberto Machado, Coordenadores de Campo: Eliete Morishige Yokoya, Maria Cec&#237;lia Guimar&#227;es M. Arruda;</p>
    <p><bold>Sorocaba:</bold> Investigador(a): Dr. Jo&#227;o N&#243;brega de Almeida Filho, Coordenador(a) de Campo: Cl&#225;udia Cristina Pereira Rabello;</p>
    <p><bold>22) Sergipe</bold> - <bold>Aracaju:</bold> Investigador(a): Dra. Geodete Batista Costa, Coordenador(a) de Campo: Thiago Augusto Silva Nascimento.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Belch JJ, Topol EJ, Agnelli G, Bertrand M,    Califf RM, Clement DL, et al. Critical issues in peripheral arterial disease    detection and management: a call to action. Arch Intern Med. 2003; 163: 884-92.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Critical issues in peripheral arterial disease detection and management: a call to action</article-title>
          <source>Arch Intern Med</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>884</fpage>
          <lpage>92</lpage>
          <volume>163</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Belch</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Topol</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Agnelli</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bertrand</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Califf</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Clement</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation>2. Task Working Group. Management of Peripheral Arterial Disease (PAD) TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000; 31 (1 Pt 2): S1-S288.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Management of Peripheral Arterial Disease (PAD) TransAtlantic Inter-Society Consensus (TASC)</article-title>
          <source>J Vasc Surg</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>S1</fpage>
          <lpage>S288</lpage>
          <issue>1</issue>
          <volume>31</volume>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Howell MA, Colgan MP, Seeger RW, Ramsey DE,    Summer DS. Relationship of severity of lower limb peripheral vascular disease    to mortality and morbidity: a six-year follow-up study. J Vasc Surg. 1989; 9:    691-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: a six-year follow-up study</article-title>
          <source>J Vasc Surg</source>
          <date>
            <year>1989</year>
          </date>
          <fpage>691</fpage>
          <lpage>6</lpage>
          <volume>9</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Howell</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Colgan</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Seeger</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Ramsey</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Summer</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Criqui MH, Langer RD, Fronek A, Feigelson    HS, Klauber MR, McCann TJ, et al. Mortality over a period of 10 years in patients    with peripheral arterial disease. N Engl J Med. 1992; 326: 381-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Mortality over a period of 10 years in patients with peripheral arterial disease</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>1992</year>
          </date>
          <fpage>381</fpage>
          <lpage>6</lpage>
          <volume>326</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Criqui</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Langer</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Fronek</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Feigelson</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Klauber</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>McCann</surname>
              <given-names>TJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. McDermott MM, Feinglass J, Slavensky R, Pearce    WH. The ankle-brachial index as a predictor of survival in patients with peripheral    vascular disease. J Gen Intern Med. 1994; 9: 445-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The ankle-brachial index as a predictor of survival in patients with peripheral vascular disease</article-title>
          <source>J Gen Intern Med</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>445</fpage>
          <lpage>9</lpage>
          <volume>9</volume>
          <person-group person-group-type="author">
            <name>
              <surname>McDermott</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Feinglass</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Slavensky</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pearce</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Cobb FR, Kraus WE, Root M, Allen JD. Assessing    risk for coronary heart disease: beyond Framingham. Am Heart J. 2003; 146 (4):    572-80.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Assessing risk for coronary heart disease: beyond Framingham</article-title>
          <source>Am Heart J</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>572</fpage>
          <lpage>80</lpage>
          <issue>4</issue>
          <volume>146</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cobb</surname>
              <given-names>FR</given-names>
            </name>
            <name>
              <surname>Kraus</surname>
              <given-names>WE</given-names>
            </name>
            <name>
              <surname>Root</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation>7. Sociedade Brasileira de Cardiologia. IV Diretriz brasileira sobre dislipidemias e preven&#231;&#227;o da aterosclerose. Arq Bras Cardiol. 2007; 88 (supl. I): 1-19.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>IV Diretriz brasileira sobre dislipidemias e preven&#231;&#227;o da aterosclerose</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>1</fpage>
          <lpage>19</lpage>
          <volume>88</volume>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Passos VMA, Barreto SM, Guerra HL, Firmo JOA,    Vidigal PG, Lima-Costa MFF. The Bambu&#237; Health and Aging Study (aBHAS):    prevalence of intermittent claudication in the aged population of the community    of Bambu&#237; and its associated factors. Arq Bras Cardiol. 2001; 77: 458-62.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The Bambu&#237; Health and Aging Study (aBHAS): prevalence of intermittent claudication in the aged population of the community of Bambu&#237; and its associated factors</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>458</fpage>
          <lpage>62</lpage>
          <volume>77</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Passos</surname>
              <given-names>VMA</given-names>
            </name>
            <name>
              <surname>Barreto</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Guerra</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Firmo</surname>
              <given-names>JOA</given-names>
            </name>
            <name>
              <surname>Vidigal</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Lima-Costa</surname>
              <given-names>MFF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Makdisse M, Ramos LR, Moreira F, Oliveira    A, Berwanger O, Moscardi A, et al. A risk score for predicting peripheral arterial    disease in individuals 75 years or older. Arq Bras Cardiol. 2007; 88 (6): 630-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A risk score for predicting peripheral arterial disease in individuals 75 years or older</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>630</fpage>
          <lpage>6</lpage>
          <issue>6</issue>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Makdisse</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ramos</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Moreira</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Berwanger</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Moscardi</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Carmo WB, Pinheiro HS, Bastos MG. Doen&#231;a    arterial obstrutiva de membros inferiores em pacientes com doen&#231;a renal    cr&#244;nica pr&#233;-dial&#237;tica. J Bras Nefrol. 2007; 29 (3): 127-34.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Doen&#231;a arterial obstrutiva de membros inferiores em pacientes com doen&#231;a renal cr&#244;nica pr&#233;-dial&#237;tica</article-title>
          <source>J Bras Nefrol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>127</fpage>
          <lpage>34</lpage>
          <issue>3</issue>
          <volume>29</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Carmo</surname>
              <given-names>WB</given-names>
            </name>
            <name>
              <surname>Pinheiro</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Bastos</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Makdisse M. &#205;ndice tornozelo-braquial:    import&#226;ncia e uso na pr&#225;tica cl&#237;nica. S&#227;o Paulo:    Editora Segmento Farma; 2004.</mixed-citation>
        <element-citation publication-type="book">
          <source>&#205;ndice tornozelo-braquial: import&#226;ncia e uso na pr&#225;tica cl&#237;nica</source>
          <date>
            <year>2004</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Makdisse</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Makdisse M, Nascimento Neto R, Chagas ACP,    Brasil D, Borges JL, Oliveira A, et al. Vers&#227;o em portugu&#234;s, adapta&#231;&#227;o    transcultural e valida&#231;&#227;o do question&#225;rio de claudica&#231;&#227;o    de Edimburgo". Arq Bras Cardiol. 2007; 88 (5): 501-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Vers&#227;o em portugu&#234;s, adapta&#231;&#227;o transcultural e valida&#231;&#227;o do question&#225;rio de claudica&#231;&#227;o de Edimburgo"</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>501</fpage>
          <lpage>6</lpage>
          <issue>5</issue>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Makdisse</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nascimento Neto</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Chagas</surname>
              <given-names>ACP</given-names>
            </name>
            <name>
              <surname>Brasil</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Borges</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Hosmer DW, Lemeshow S. Applied logistic regression.    2nd ed. New York: John Wiley; 2000.</mixed-citation>
        <element-citation publication-type="book">
          <source>Applied logistic regression</source>
          <date>
            <year>2000</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Hosmer</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Lemeshow</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Archer KJ, Lemeshow S. Goodness-of-fit test    for a logistic regression model fitted using survey sample data. The Stata J.    2006; 6 (1): 97-105.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Goodness-of-fit test for a logistic regression model fitted using survey sample data</article-title>
          <source>The Stata J</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>97</fpage>
          <lpage>105</lpage>
          <issue>1</issue>
          <volume>6</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Archer</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Lemeshow</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Curb JD, Masaki K, Rodriguez BL, Abbott RD,    Burchfiel CM, Chen R, et al. Peripheral artery disease and cardiovascular risk    factors in the elderly. The Honolulu Heart Program. 1: Arterioscler Thromb Vasc    Biol. 1996; 16 (12): 1495-500.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Peripheral artery disease and cardiovascular risk factors in the elderly: The Honolulu Heart Program. 1</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>1495</fpage>
          <lpage>500</lpage>
          <issue>12</issue>
          <volume>16</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Curb</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Masaki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Rodriguez</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Abbott</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Burchfiel</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Diehm C, Schuster A, Allenberg JR, Darius    H, Haberl R, Lange S, et al. High prevalence of peripheral arterial disease    and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis.    2004; 172 (1): 95-105.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study</article-title>
          <source>Atherosclerosis</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>95</fpage>
          <lpage>105</lpage>
          <issue>1</issue>
          <volume>172</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Diehm</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schuster</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Allenberg</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Darius</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Haberl</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lange</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Newman AB, Siscovick DS, Manolio TA, Polak    J, Fried LP, Borhani NO, et al. Ankle-arm index as a marker of atherosclerosis    in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative    Research Group. Circulation. 1993; 88 (3): 837-45.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study: Cardiovascular Heart Study (CHS) Collaborative Research Group</article-title>
          <source>Circulation</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>837</fpage>
          <lpage>45</lpage>
          <issue>3</issue>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Newman</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Siscovick</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Manolio</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Polak</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fried</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Borhani</surname>
              <given-names>NO</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Murabito JM, Evans JC, Larson MG, Nieto K,    Levy D, Wilson PW. The ankle-brachial index in the elderly and risk of stroke,    coronary disease, and death: the Framingham Study. Arch Intern Med. 2003; 163    (16): 1939-42.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study</article-title>
          <source>Arch Intern Med</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>1939</fpage>
          <lpage>42</lpage>
          <issue>16</issue>
          <volume>163</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Murabito</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Larson</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Nieto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>PW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Selvin E, Erlinger TP. Prevalence of and    risk factors for peripheral arterial disease in the United States: results from    the National Health and Nutrition Examination Survey, 1999-2000. Circulation.    2004; 110 (6): 738-43.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000</article-title>
          <source>Circulation</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>738</fpage>
          <lpage>43</lpage>
          <issue>6</issue>
          <volume>110</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Selvin</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Erlinger</surname>
              <given-names>TP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Murabito JM, Evans JC, Nieto K, Larson MG,    Levy D, Wilson PW. Prevalence and clinical correlates of peripheral arterial    disease in the Framingham Offspring Study. Am Heart J. 2002; 143 (6): 961-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study</article-title>
          <source>Am Heart J</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>961</fpage>
          <lpage>5</lpage>
          <issue>6</issue>
          <volume>143</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Murabito</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Nieto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Larson</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>PW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Zheng ZJ, Rosamond WD, Chambless LE, Nieto    FJ, Barnes RW, Hutchinson RG, et al. ARIC Investigators. Lower extremity arterial    disease assessed by ankle-brachial index in a middle-aged population of African    Americans and whites: the Atherosclerosis Risk in Communities (ARIC) Study.    Am J Prev Med. 2005; 29 (5 Suppl 1): 42-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>ARIC Investigators. Lower extremity arterial disease assessed by ankle-brachial index in a middle-aged population of African Americans and whites: the Atherosclerosis Risk in Communities (ARIC) Study</article-title>
          <source>Am J Prev Med</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>42</fpage>
          <lpage>9</lpage>
          <issue>5</issue>
          <volume>29</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Zheng</surname>
              <given-names>ZJ</given-names>
            </name>
            <name>
              <surname>Rosamond</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Chambless</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Nieto</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Barnes</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Hutchinson</surname>
              <given-names>RG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Lamina C, Meisinger C, Heid IM, L&#246;wel    H, Rantner B, Koenig W, et al; Kora Study Group. Association of ankle-brachial    index and plaques in the carotid and femoral arteries with cardiovascular events    and total mortality in a population-based study with 13 years of follow-up.    Eur Heart J. 2006; 27 (21): 2580-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Kora Study Group. Association of ankle-brachial index and plaques in the carotid and femoral arteries with cardiovascular events and total mortality in a population-based study with 13 years of follow-up</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>2580</fpage>
          <lpage>7</lpage>
          <issue>21</issue>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lamina</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Meisinger</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Heid</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>L&#246;wel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Rantner</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Koenig</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Criqui MH, Vargas V, Denenberg JO, Ho E,    Allison M, Langer RD, et al. Ethnicity and peripheral arterial disease: the    San Diego Population Study. Circulation. 2005; 112 (17): 2703-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Ethnicity and peripheral arterial disease: the San Diego Population Study</article-title>
          <source>Circulation</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>2703</fpage>
          <lpage>7</lpage>
          <issue>17</issue>
          <volume>112</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Criqui</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Vargas</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Denenberg</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Allison</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Langer</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Fowkes FG, Thorogood M, Connor MD, Lewando-Hundt    G, Tzoulaki I, Tollman SM. Distribution of a subclinical marker of cardiovascular    risk, the ankle brachial index, in a rural African population: SASPI study.    Eur J Cardiovasc Prev Rehabil. 2006; 13 (6): 964-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Distribution of a subclinical marker of cardiovascular risk, the ankle brachial index, in a rural African population: SASPI study</article-title>
          <source>Eur J Cardiovasc Prev Rehabil</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>964</fpage>
          <lpage>9</lpage>
          <issue>6</issue>
          <volume>13</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fowkes</surname>
              <given-names>FG</given-names>
            </name>
            <name>
              <surname>Thorogood</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Connor</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Lewando-Hundt</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tzoulaki</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Tollman</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Fowkes FG, Low LP, Tuta S, Kozak J; AGATHA    Investigators. Ankle-brachial index and extent of atherothrombosis in 8891 patients    with or at risk of vascular disease: results of the international AGATHA study.    Eur Heart J. 2006; 27 (15): 1861-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease: results of the international AGATHA study</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>1861</fpage>
          <lpage>7</lpage>
          <issue>15</issue>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fowkes</surname>
              <given-names>FG</given-names>
            </name>
            <name>
              <surname>Low</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Tuta</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kozak</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner    JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness,    and treatment in primary care. JAMA. 2001; 286 (11): 1317-24.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Peripheral arterial disease detection, awareness, and treatment in primary care</article-title>
          <source>JAMA</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>1317</fpage>
          <lpage>24</lpage>
          <issue>11</issue>
          <volume>286</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hirsch</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Criqui</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Treat-Jacobson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Regensteiner</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Creager</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Olin</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Sigvant B, Wiberg-Hedman K, Bergqvist D,    Rolandsson O, Andersson B, Persson E, et al. A population-based study of peripheral    arterial disease prevalence with special focus on critical limb ischemia and    sex differences. J Vasc Surg. 2007; 45 (6): 1185-91.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences</article-title>
          <source>J Vasc Surg</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>1185</fpage>
          <lpage>91</lpage>
          <issue>6</issue>
          <volume>45</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sigvant</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wiberg-Hedman</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bergqvist</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rolandsson</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Andersson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Persson</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. McDermott MM, Fried L, Simonsick E, Ling    S, Guralnik JM. Asymptomatic peripheral arterial disease is independently associated    with impaired lower extremity functioning. The Women's Health and Aging Study.    Circulation. 2000; 101: 1007-12.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: The Women's Health and Aging Study</article-title>
          <source>Circulation</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>1007</fpage>
          <lpage>12</lpage>
          <volume>101</volume>
          <person-group person-group-type="author">
            <name>
              <surname>McDermott</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Fried</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Simonsick</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ling</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Guralnik</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Vliegenthart R, Geleijnse JM, Hofman A, Meijer    WT, Van Rooij FJA, Grobbee DE, et al. Alcohol consumption and risk of peripheral    arterial disease. The Rotterdam Study. Am J Epidemiol. 2002; 155: 332-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Alcohol consumption and risk of peripheral arterial disease: The Rotterdam Study</article-title>
          <source>Am J Epidemiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>332</fpage>
          <lpage>8</lpage>
          <volume>155</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Vliegenthart</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Geleijnse</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Hofman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Meijer</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Van Rooij</surname>
              <given-names>FJA</given-names>
            </name>
            <name>
              <surname>Grobbee</surname>
              <given-names>DE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <mixed-citation>30. Ness J, Aronow WS. Prevalence of coexistence    of coronary artery disease, ischemic stroke, and peripheral arterial disease    in older persons, mean age 80 years, in an academic hospital-based geriatrics    practice. J Am Geriatr Soc. 1999; 47: 1255-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice</article-title>
          <source>J Am Geriatr Soc</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>1255</fpage>
          <lpage>6</lpage>
          <volume>47</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ness</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Aronow</surname>
              <given-names>WS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B31">
        <mixed-citation>31. Newman AB, Sutton-Tyrrell K, Kuller LH. Lower-extremity    arterial disease in older hypertensive adults. Arterioscler Thromb Vasc Biol.    1993; 13: 555-62.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Lower-extremity arterial disease in older hypertensive adults</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>555</fpage>
          <lpage>62</lpage>
          <volume>13</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Newman</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Sutton-Tyrrell</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kuller</surname>
              <given-names>LH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B32">
        <mixed-citation>32. O'Hare A, Johansen K. Lower-extremity peripheral    arterial disease among patients with end-stage renal disease. J Am Soc Nephrol.    2001; 12: 2838-47.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Lower-extremity peripheral arterial disease among patients with end-stage renal disease</article-title>
          <source>J Am Soc Nephrol</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>2838</fpage>
          <lpage>47</lpage>
          <volume>12</volume>
          <person-group person-group-type="author">
            <name>
              <surname>O'Hare</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Johansen</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B33">
        <mixed-citation>33. Newman AB, Shemanski L, Manolio TA, Cushman    M, Mittelmark M, Polak JF, et al. Ankle-arm index as a predictor of cardiovascular    disease and mortality in the cardiovascular health study. Arterioscler Thromb    Vasc Biol. 1999; 19; 538-45.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Ankle-arm index as a predictor of cardiovascular disease and mortality in the cardiovascular health study</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>538</fpage>
          <lpage>45</lpage>
          <volume>19</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Newman</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Shemanski</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Manolio</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Cushman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mittelmark</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Polak</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B34">
        <mixed-citation>34. Diehm C, Lange S, Trampisch HJ, Haberl R,    Darius H, Von Stritzky B, et al. Relationship between lipid parameters and the    presence of peripheral arterial disease in elderly patients. Curr Med Res Opin.    2004; 20: 1873-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Relationship between lipid parameters and the presence of peripheral arterial disease in elderly patients</article-title>
          <source>Curr Med Res Opin</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>1873</fpage>
          <lpage>5</lpage>
          <volume>20</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Diehm</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lange</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Trampisch</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Haberl</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Darius</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Von Stritzky</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B35">
        <mixed-citation>35. Elhadd TA, Robb R, Jung RT, Stonebridge PA,    Belch JJF. Pilot study of prevalence of asymptomatic peripheral arterial occlusive    disease in patients with diabetes attending a hospital clinic. Pract Diabetes    Int. 1999; 16: 163-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Pilot study of prevalence of asymptomatic peripheral arterial occlusive disease in patients with diabetes attending a hospital clinic</article-title>
          <source>Pract Diabetes Int</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>163</fpage>
          <lpage>6</lpage>
          <volume>16</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Elhadd</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Robb</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Stonebridge</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Belch</surname>
              <given-names>JJF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B36">
        <mixed-citation>36. Jensen SA, Vatten LJ, Nilsen TIL, Romundstad    PR, Myhre HO. Serum lipids and anthropometric factors related to the prevalence    of intermittent claudication. Eur J Vasc Endovasc Surg. 2005; 30 (6): 582-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Serum lipids and anthropometric factors related to the prevalence of intermittent claudication</article-title>
          <source>Eur J Vasc Endovasc Surg</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>582</fpage>
          <lpage>7</lpage>
          <issue>6</issue>
          <volume>30</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jensen</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Vatten</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Nilsen</surname>
              <given-names>TIL</given-names>
            </name>
            <name>
              <surname>Romundstad</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Myhre</surname>
              <given-names>HO</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B37">
        <mixed-citation>37. Planas A, Clara A, Pou J-M, Vidal-Barraquer    F, Gasol A, De Moner A, et al. Relationship of obesity distribution and peripheral    arterial occlusive disease in elderly men. Int J Obes. 2001; 25: 1068-70.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Relationship of obesity distribution and peripheral arterial occlusive disease in elderly men</article-title>
          <source>Int J Obes</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>1068</fpage>
          <lpage>70</lpage>
          <volume>25</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Planas</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Clara</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pou</surname>
              <given-names>J-M</given-names>
            </name>
            <name>
              <surname>Vidal-Barraquer</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Gasol</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>De Moner</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B38">
        <mixed-citation>38. Collins TC, Petersen NJ, Suarez-Almazor M,    Ashton CM. The prevalence of peripheral arterial disease in a racially diverse    population. Arch Intern Med. 2003; 163: 1469-74.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The prevalence of peripheral arterial disease in a racially diverse population</article-title>
          <source>Arch Intern Med</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>1469</fpage>
          <lpage>74</lpage>
          <volume>163</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Collins</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Petersen</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Suarez-Almazor</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ashton</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B39">
        <mixed-citation>39. Criqui MH, Fronek A, Klauber MR, Barrett-Connor    E, Gabriel S. Sensitivity, specificity, and predictive value of traditional    evaluation of peripheral arterial disease: results from noninvasive testing    in a defined population. Circulation. 1985; 71: 516-22.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Sensitivity, specificity, and predictive value of traditional evaluation of peripheral arterial disease: results from noninvasive testing in a defined population</article-title>
          <source>Circulation</source>
          <date>
            <year>1985</year>
          </date>
          <fpage>516</fpage>
          <lpage>22</lpage>
          <volume>71</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Criqui</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Fronek</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Klauber</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Barrett-Connor</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Gabriel</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
    <app-group><app id="ape"><label>ap&#234;ndice</label></app>Ap&#234;ndice: patrocinadores, capacitadores, investigadores e coordenadores de campo do Projeto Cora&#231;&#245;es do Brasil </app-group>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Prevalence and risk factors associated with peripheral arterial disease in the hearts of Brazil project</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: Peripheral arterial disease (PAD) is associated with increased cardiovascular risk. In Brazil, data on PAD prevalence and risk factors are scarce. OBJECTIVE: To assess prevalence and risk factors related to PAD in Brazilian urban centers with more than 100,000 inhabitants. METHODS: National, multicenter, cross-sectional study of 1,170 individuals (&gt;18 years), from 72 major Brazilian urban centers participating in the "Hearts of Brazil Project". PAD diagnosis was based on ankle-brachial index (ABI) &lt; 0.90. The statistical analysis used the corrected Chi-square (Pearson) test for complex samples and confidence intervals. P&lt; 0.05 was considered statitically significant. RESULTS: PAD prevalence was 10.5%. Intermittent claudication (IC) was present in only 9% of PAD patients. A significant association was found between PAD and the following factors: diabetes, total and abdominal obesity, stroke and ischemic heart disease (IHD). There was a trend of higher PAD prevalence among individuals with hypertension, heart failure, chronic renal failure on dialysis, as well as those who had smoked over 20 pack-years. For females, presence of IHD was associated with a 4.9-fold greater risk of PAD. Among males, a 6.6-fold increased risk of PAD was found for diabetic in comparison to non-diabetic individuals. CONCLUSION: PAD prevalence was markedly high, considering the low mean age of the studied population (44&#177;14.7 yrs). IC was detected in a minority of PAD subjects, indicating a considerable number of asymptomatic individuals. Diabetes, obesity, stroke and IHD were the stronger predictors of PAD. The authors concluded that ABI measurement should be considered in the evaluation of moderate to high cardiovascular risk patients.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Arterial occlusive diseases</kwd>
        <kwd>prevalence</kwd>
        <kwd>risk factors</kwd>
        <kwd>Brazil</kwd>
        <kwd>intermittent claudication</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ORIGINAL ARTICLE</bold>
      </p>
      <p><undefined id="tx-body2"/>Prevalence and risk factors associated with peripheral arterial disease in the hearts of Brazil project</p>
      <p>
        <bold>Marcia Makdisse<sup>I, II</sup>; Alexandre da Costa Pereira<sup>III</sup>; David de P&#225;dua Brasil<sup>IV</sup>; Jairo Lins Borges<sup>V</sup>; George Luiz Lins Machado-Coelho<sup>VI</sup>; Jos&#233; Eduardo Krieger<sup>III</sup>; Raimundo Marques Nascimento Neto<sup>VI</sup>; Antonio Carlos Palandri Chagas<sup>III</sup>; on behalf of the investigators of the Hearts of Brazil Study and Peripheral Arterial Disease Committee of the Brazilian Society of Cardiology/Funcor</bold>
      </p>
      <p><sup>I</sup>Hospital Israelita Albert Einstein, S&#227;o Paulo, SP - Brazil</p>
      <p><sup>II</sup>Universidade Federal de S&#227;o Paulo (Unifesp), S&#227;o Paulo, SP - Brazil</p>
      <p><sup>III</sup>Instituto do Cora&#231;&#227;o da Faculdade de Medicina da Universidade de S&#227;o Paulo (Incor USP), S&#227;o Paulo, SP - Brazil</p>
      <p><sup>IV</sup>Faculdade de Ci&#234;ncias M&#233;dicas de Minas Gerais, Belo Horizonte, MG - Brazil</p>
      <p><sup>V</sup>Instituto Dante Pazzanese de Cardiologia, S&#227;o Paulo, SP - Brazil</p>
      <p><sup>VI</sup>Departamento de Ci&#234;ncias M&#233;dicas da Universidade Federal de Ouro Preto, Ouro Preto, MG - Brazil</p>
      <p>Mailing Address</p>
      <p>
        <bold>SUMMARY</bold>
      </p>
      <p><bold>BACKGROUND:</bold> Peripheral arterial disease (PAD) is associated with increased cardiovascular risk. In Brazil, data on PAD prevalence and risk factors are scarce.</p>
      <p><bold>OBJECTIVE:</bold> To assess prevalence and risk factors related to PAD in Brazilian urban centers with more than 100,000 inhabitants.</p>
      <p><bold>METHODS:</bold> National, multicenter, cross-sectional study of 1,170 individuals (<underline>&gt;</underline>18 years), from 72 major Brazilian urban centers participating in the "Hearts of Brazil Project". PAD diagnosis was based on ankle-brachial index (ABI) <underline>&lt;</underline> 0.90. The statistical analysis used the corrected Chi-square (Pearson) test for complex samples and confidence intervals. P&lt; 0.05 was considered statitically significant.</p>
      <p><bold>RESULTS:</bold> PAD prevalence was 10.5%. Intermittent claudication (IC) was present in only 9% of PAD patients. A significant association was found between PAD and the following factors: diabetes, total and abdominal obesity, stroke and ischemic heart disease (IHD). There was a trend of higher PAD prevalence among individuals with hypertension, heart failure, chronic renal failure on dialysis, as well as those who had smoked over 20 pack-years. For females, presence of IHD was associated with a 4.9-fold greater risk of PAD. Among males, a 6.6-fold increased risk of PAD was found for diabetic in comparison to non-diabetic individuals.</p>
      <p><bold>CONCLUSION:</bold> PAD prevalence was markedly high, considering the low mean age of the studied population (44&#177;14.7 yrs). IC was detected in a minority of PAD subjects, indicating a considerable number of asymptomatic individuals. Diabetes, obesity, stroke and IHD were the stronger predictors of PAD. The authors concluded that ABI measurement should be considered in the evaluation of moderate to high cardiovascular risk patients.</p>
      <p><bold>Key words:</bold> Arterial occlusive diseases; prevalence; risk factors; Brazil; intermittent claudication.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>It is estimated that 27 million individuals have peripheral arterial disease (PAD) in Europe and North America<sup>1</sup>. This number might be underestimated, as most of the patients is asymptomatic or does not present the classic symptom of the disease, intermittent claudication<sup>2</sup>.</p>
      <p>The PAD, both symptomatic and asymptomatic, is associated to obstructive arterial disease in other vascular beds (coronary, cerebral, carotid) and, consequently, to a higher risk of cardiovascular events (death, acute myocardial infarction, cerebral vascular accident), of around 4 to 6% a year, in individuals with the disease<sup>3-5</sup>.</p>
      <p>The assessment of the asymptomatic PAD through the ankle-brachial index (ABI) has become an important tool in the stratification of cardiovascular risk, especially in patients with intermediate risk<sup>6-7</sup>.</p>
      <p>In Brazil, study data related to the prevalence of DAP and its risk factors are scarce and restricted to specific populations, with almost all of them carried out in the Southeast region of the country. Among them, two population-based studies are noteworthy: The Bambui Project, which evaluated 1,485 elderly individuals (<underline>&gt;</underline> 65 years) that lived in Bambui (state of Minas Gerais), and showed a prevalence of 2.5% of intermittent claudication<sup>8</sup> and the Epidoso Study, which evaluated 176 elderly individuals (<underline>&gt;</underline> 75 years), living in the city of Sao Paulo, through the ABI and found a prevalence of 36.4% of PAD<sup>9</sup>. A more recent study, also carried out in the state of Minas Gerais, found 37.5% of PAD in patients with pre-dialytic chronic kidney disease<sup>10</sup>.</p>
      <p>Considering that, the primary objective of the present study was to evaluate, through the ABI, the prevalence of symptomatic and asymptomatic PAD in a proportional population sample from 72 Brazilian urban centers with more than 100,000 inhabitants. The secondary objective was to correlate the diagnosis of PAD to several sociodemographic variables, presence of cardiovascular risk factors and the presence of comorbidities.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>
        <bold>Study Design</bold>
      </p>
      <p>Transversal, multicenter observational cohort study.</p>
      <p>
        <bold>Population</bold>
      </p>
      <p>The universe of the study consisted in the set of inhabitants of Brazilian urban centers with more than 100,000 inhabitants in 2004, aged <underline>&gt;</underline> 18 years.</p>
      <p>
        <bold>Sample Plan</bold>
      </p>
      <p>This is a stratified sample with a bietapic sampling, calculated as 2,500 interviews, distributed in the regions proportionally to the number of inhabitants, per sex and age range, based on data from IBGE (Instituto Brasileiro de Geografia e Estat&#237;stica - The Brazilian Institute of Geography and Statistics). A total of 72 cities were chosen in the five regions. The minimum sample size was set at 15, for smaller towns, up to 400, for the city of Sao Paulo. In the selected cities, the "households" constituted the second-stage units, with one interview per household.</p>
      <p>The choice of the individual occurred in three stages. In the cities, the census sectors were selected. In the sectors, one street was elected and following randomization rules (random start and fixed interval of 10 households), the household was chosen. The respondent was selected based on pre-defined criteria (birth date closest to the date of the interview), respecting the stratification per sex and age. When the respondent was not present at the first contact, he/she could be sampled at two subsequent visits at another date, by the same interviewer. The interviewees were invited to attend a medical consultation on an appropriate day. The planning previewed 7 to 8 interviews per census sector, characterizing a third stage in the sample plan.</p>
      <p>
        <bold>Observed sample</bold>
      </p>
      <p>Of a total of 2,520 home interviews, 1,134 individuals attended the medical consultation. The distribution of these individuals did not follow the distribution of the household sample and some urban centers did not have volunteers for the second phase. Consequently, a supplementary sampling was carried out, with 498 telephone interviews in Sao Paulo, Rio de Janeiro, Belo Horizonte and Florianopolis. In those cities, 141 individuals attended the medical consultation and underwent a medical assessment. Two cities - Manaus and Vitoria &#150; were disregarded from the analysis of risk factors, as they had only one individual in this sample. The sample, with ABI measurement and risk factor information, consisted of 1,170 individuals. The Project was approved by the Ethics Committee in Research of the Institute of Arterial Hypertension of Minas Gerais and, as suggested by The National Committee of Ethics in Research (Comissao Nacional de Etica em Pesquisa - CONEP), was submitted and approved by the National Council of City Secretaries of Health (Conselho Nacional dos Secretarios Municipais de Saude - CONASEMS), which facilitated the contact between the field researchers and the City Secretaries of Health. All the participants signed the Free and Informed Consent Form.</p>
      <p>
        <bold>Data collection</bold>
      </p>
      <p>The data collection occurred in two stages. The first, started in July 2004, was carried out by professionals from the Vox Populi Survey Institute, which applied structured questionnaires during the household interview. At the second stage, a standard medical consultation was carried out, with medical questionnaires, clinical examination, blood pressure measurements, anthropometric measurements, ABI and biological material collection.</p>
      <p>
        <bold>PAD Assessment</bold>
      </p>
      <p>The presence of PAD was assessed through the measurement of ABI, which was measured at rest in the supine position, with a portable vascular Doppler equipment (MEDPEJ DV-2001, 10 MHZ) and sphygmomanometer. The cuff size was selected based on the right brachial circumference (BC, measured at midpoint between the acromion and the olecranon: BC &lt; 25 cm (small size), BC = 25-32 cm (middle size), BC= 32-42 cm (large size) and BC &gt; 42 cm (thigh). To standardize the ABI measurement technique, at least one researcher from each center (doctor and/or nurse) was trained in ABI workshops, coordinated by the main author. The systolic pressure was measured twice in each artery, in the arms (brachial artery) and ankles (pedal artery and posterior tibial artery).</p>
      <p>The pressure recorded for each artery was the mean of two measurements, as long as the difference between them was <underline>&lt;</underline> 6 mmHg; otherwise, another pair of measurements was carried out. To calculate the ABI, we used the highest systolic pressure of the ankle (mean pedal or mean posterior tibial pressure), divided by the highest arm pressure (right brachial or mean left pressure), with a value of ABI being calculated for each lower limb<sup>11</sup>.</p>
      <p>ABI values <underline>&lt;</underline> 0.90 in one or both lower limbs were considered diagnostic of PAD. The absence of PAD was defined as levels of ABI from 0.91 to 1.40, in the absence of arterial revascularization of the lower limbs. ABI values &gt; 1.40 were excluded from the analysis, as they do not define the diagnosis of PAD.</p>
      <p>
        <bold>Intermittent claudication assessment</bold>
      </p>
      <p>The presence of intermittent claudication was defined by the criteria of the Edinburgh Claudication Questionnaire, validated for Brazilian Portuguese<sup>12</sup>.</p>
      <p>
        <bold>Definition of ankle pulse abnormalities</bold>
      </p>
      <p>The palpation of the ankle pulses was carried out bilaterally in the pedal and posterior tibial arteries and classified as present or absent.</p>
      <p>
        <bold>Laboratory assessment</bold>
      </p>
      <p>At the second stage, after fasting, capillary examinations were carried out by the use of the point-of-care technology (Roche Diagnostics, Accu-Check) for the assessment of capillary glycemia, total cholesterol and triglycerides.</p>
      <p>
        <bold>Statistical analysis</bold>
      </p>
      <p>The prevalence estimates were calculated based on a complex sampling model. Each individual was assigned a weight, according to his/her sex, city and region. The association between PAD and each variable was determined by Pearson's Chi-square test (X<sup>2</sup>), corrected by the complex sampling plan. P values <underline>&lt;</underline> 0.05 were considered indicative of significant association between PAD and the variable. The comparison of the means of the continuous variables was carried out through confidence intervals (CI), based on the complex sampling plan. In the absence of overlapping between the CI, it was considered that there was a significant difference.</p>
      <p>A multivariable logistic regression model was constructed according to the methodology of Hosmer and Lemeshow<sup>13</sup>. Initially, univariable analyses were performed to obtain crude Odds Ratios (OR). Then, the multivariable analysis was started, including the listed variables (sex, smoking status, hypertension, diabetes, age, obesity, cholesterol and triglycerides) as possible predictors of PAD and the socioeconomic variables that could have an impact on the health-related phenomena, such as family income and schooling.</p>
      <p>The variables sex, smoking status, hypertension, diabetes, age and obesity were categorized as 0 (absent) or 1 (present) and the variables cholesterol and triglycerides were included as continuous variables. Individuals were considered hypertensive when they were known to be hypertensive, used antihypertensive medication, or whose blood pressure on the day of the medical consultation showed to be &gt; 140x90 mmHg; individuals were considered diabetics when they were known to have diabetes, used antidiabetic drugs medication or had capillary glycemia &gt; 126 mg/dL on the day of the medical consultation; individuals were considered to be hypercholesterolemic when they were known to have hypercholesterolemia, used lipid lowering medication or had total cholesterol &gt; 200 mg/dL on the day of the medical consultation.</p>
      <p>At this phase, variables included in the model presented a p &lt; 0.25. Due to the multicolinearity between income and schooling, only the variable schooling, categorized as 0 (illiterate), 1 (complete or incomplete Elementary School) or 2 (High School or College/University) was maintained.</p>
      <p>The data were analyzed with the software packages Stata (Release 9) and SPSS 13.0 for Windows (Statistical Package for Social Sciences), Complex Samples module.</p>
      <p>At the third phase, the possible interactions with a biological meaning and/or evidence of importance at the analyses of the crossed tables were included, considering p (entry) &lt; 0.25. In the final model, the variables that presented significance at 5% remained or those which, even though were not significant, were confounders. The modeling process was concluded and the colinearity and confounding were tested between the risk factors at each step. The adjusted statistical model was represented by the equation:</p>
      <p>
        <graphic xlink:href="1678-4170-abc-91-06-0402-00008-e01-en.jpg"/></p>
      <p>where &#946;i (i = 0,1,...,8) are the coefficients of the terms of the model, x<sub>1</sub> = Diabetes, x<sub>2</sub> = Sex, x<sub>3</sub> = Ischemic heart disease (IHD), x<sub>4</sub> = Hypertension, x<sub>5</sub> = College/University education.</p>
      <p> The OR of the variables not present in the interactions were obtained by the exponentiation of the &#946; coefficients. When there is an interaction between a factor and another variable, the OR estimate for the factor depends on the value of the variable that is interacting with it. In this situation, due to the impossibility of estimating the OR by simple exponentiation of the &#946; coefficient, we used the differences between logits, defined as a function of model. As the statistical packages did not have a routine to calculate OR and CI for interactions, they were calculated manually by the team based on the methodology of Archer and Lemeshow<sup>14</sup>. The final model contains the interactions Diabetes X Sex, IHD X Sex and Hypertension X College/University education. The model adjustment was verified by the test of Hosmer and Lemeshow, with the software Stata, using an adequate procedure (Archer, K.J. &amp; Lemeshow S., 2006) developed for the aforementioned test in complex samples. With this procedure, we obtained the value: F<italic>-adjusted</italic> = 0.266 and p = 0.98.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>Of a total of 1,170 individuals, 11 were excluded due to ABI &gt; 1.40 (0.85%), resulting in a final sample of 1,159. There was a predominance of young adults (53.6% aged up to 45 years, 30.8% between 45 and 59 years and 15.6% <underline>&gt;</underline> 60 years) and the mean age was 43.82 &#177; 14.68 years (95%CI: 43.02 &#150; 44.64), women (53.3%) and Caucasian ethnicity (Caucasian: 56.9%, Afro-descendants: 9.2%, Brazilian mulattoes: 31,8%, Brazilian natives: 0.9% and others:1.3%). Most of them had finished Elementary School (Illiterate: 2.4%, did not finish Elementary School: 9.6%, finished Elementary School: 45.0%, finished High School: 32,9% and finished College/University: 10.0%) and family income of up to 5 minimum wages (MW) (<underline>&lt;</underline> 1 MW: 8.9%, from 1 to 5 MW: 54.3%, from 5 to 10 MW: 22.6% and &gt; 10 MW: 14.2%). <xref ref-type="fig" rid="fig01-body2">Figure 1</xref> shows the distribution of the participants regarding the Brazilian regions.</p>
      <fig id="fig01-body2">
        <graphic xlink:href="1678-4170-abc-91-06-0402-00008-gf01-en.jpg"/></fig>
      <p>The prevalence of PAD was 10.5% (n=134), distributed as follows in the Brazilian regions: North/Midwest=17.8% (n=22/119), South=12.0% (24/199), Southeast=11.7% (76/592), Northeast=4.6% (12/173). There was no significant difference regarding prevalence of PAD among the regions (p=0.35).</p>
      <p>
        <bold>Univariate analysis</bold>
      </p>
      <p>The comparisons between the groups with and without PAD regarding the sociodemographic characteristics, life habits, coexisting clinical conditions, medication use, presence of symptoms, pulse evaluation and laboratory assessment are shown in <xref ref-type="table" rid="tab01-body2">Tables 1</xref>, <xref ref-type="table" rid="tab02-body2">2</xref>, <xref ref-type="table" rid="tab03-body2">3</xref> and <xref ref-type="table" rid="tab04-body2">4</xref>, respectively.</p>
      <table-wrap id="tab01-body2">
        <graphic xlink:href="1678-4170-abc-91-06-0402-00008-gt01-en.jpg"/></table-wrap>
      <table-wrap id="tab02-body2">
        <graphic xlink:href="1678-4170-abc-91-06-0402-00008-gt02-en.jpg"/></table-wrap>
      <table-wrap id="tab03-body2">
        <graphic xlink:href="1678-4170-abc-91-06-0402-00008-gt03-en.jpg"/></table-wrap>
      <table-wrap id="tab04-body2">
        <graphic xlink:href="1678-4170-abc-91-06-0402-00008-gt04-en.jpg"/></table-wrap>
      <p>
        <bold>Multivariable logistic regression</bold>
      </p>
      <p>In order to analyze the interaction IHD x Sex, the OR of the IHD were estimated for each sex (<xref ref-type="table" rid="tab05-body2">Table 5</xref>). The OR value for IHD present for the male sex was 1.21 (0.44; 3.31), which was non-significant, whereas for the female sex it was 4.92 (2.52; 9.59), highly significant, clearly showing the interaction. The analysis of the interaction Diabetes <italic>versus</italic> Sex shows that the effect of Diabetes in the male sex was highly significant OR = 6.65 (2.6; 17.01). For the female sex, this risk was not significant, with an OR = 1.19 (0.55; 2.57) (<xref ref-type="fig" rid="qdr01-body2">Chart 1</xref>).</p>
      <table-wrap id="tab05-body2">
        <graphic xlink:href="1678-4170-abc-91-06-0402-00008-gt05-en.jpg"/></table-wrap>
      <fig id="qdr01-body2">
        <graphic xlink:href="1678-4170-abc-91-06-0402-00008-gf02-en.jpg"/></fig>
      <p>The discriminatory performance of the model was validated using the C-index, which corresponds to the area under the ROC (Receiver Operation Curve). An area of 0.621 95%CI (0.568; 0.675) was obtained.</p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>The "Hearts of Brazil" Project is an epidemiological study on the prevalence of cardiovascular risk factors in a random population sample from 72 Brazilian urban centers. A population sample aged <underline>&gt;</underline> 18 years, which resided in urban centers with more than 100,000 inhabitants, was analyzed. This project was a pioneer one in Brazil, by objectively evaluating the prevalence of PAD, both symptomatic and asymptomatic, through the measurement of ABI and the Edinburgh Claudication Questionnaire<sup>12</sup>.</p>
      <p>The prevalence of PAD was 10.5%, which means approximately 6 million individuals, considering that there are 57 million inhabitants in Brazil with the characteristics of the population evaluated in this study (IBGE).</p>
      <p>The mean age was older in those individuals with PAD in comparison with individuals that did not present the disease (49.02 years x 44.23 years, p=0.049). There was an association trend between PAD and age range (p=0.08), with an increasing prevalence of the disease as the age range increased. The small number of individuals older than 60 years, as the study was not specifically designed to evaluate the prevalence of PAD, but to evaluate the several risk factors and to be representative of the Brazilian population and the broad age ranges of the study (43.82 &#177; 14.68) might have reduced the power of the sample to detect such association with a p value &lt; 0.05. However, the p value obtained indicated a consistent trend that the association between PAD and age range really existed. Studies that specifically evaluated the elderly (<underline>&gt;</underline> 65 years), reported a prevalence between 7% and 36%<sup>9,15-18 </sup>whereas, in younger populations, as the one in the present study, the prevalence ranged from 3% to 16% <sup>19-24</sup>. In populations with high cardiovascular risk, it ranged from 29% to 40.5%<sup>25,26</sup>.</p>
      <p>In the present study there was a higher prevalence of PAD among the women, similar to other published studies<sup>9,20,21,27</sup>, although a higher frequency is often reported among men<sup>16,17,22,23</sup>. In the GetABI study, the prevalence was higher among men at the younger age ranges (65-74 years), whereas it was higher among women at the older age ranges (<underline>&gt;</underline> 75 years)<sup>16</sup>.</p>
      <p>We observed a trend of higher prevalence of PAD among those that did not practice physical activity (p=0.08). The sedentary lifestyle can be seen as a risk factor for the development of PAD as well as the result of the functional impairment of the lower limbs, caused by the disease<sup>28</sup>. The prevalence of PAD was 2-fold higher among individuals that smoked &gt; 20 years/pack when compared to those who smoked fewer cigarettes. Similar data were reported by the GetABI study (34.5% and 19.5% among those who smoked &gt; 20 years/pack and &lt; 20 years/pack respectively)<sup> 16</sup>. There was no association between alcohol consumption and PAD. The Rotterdam study showed an inverse association between alcohol consumption and PAD only in non-smoking individuals<sup>29</sup>.</p>
      <p>The individuals with PAD presented a 3-fold increase in the prevalence of stroke and a 2-fold increase in the prevalence of IHD, manifesting as angina pectoris and/or myocardial infarction, in comparison to the group without PAD. The coexistence of PAD and atherosclerotic lesions in other vascular beds has been reported, especially among the elderly. In one of these studies, in the presence of DAP, the prevalence of IHD was 68% and of stroke, 42%<sup>30</sup>.</p>
      <p>There was a trend of higher prevalence of arterial hypertension, dialytic CKF and heart failure in the group with PAD. Several studies have reported these associations. In the SHEP (Systolic Hypertension in the Elderly Program) study, the prevalence of PAD among hypertensive individuals was 27%<sup>31</sup>. Among those with advanced CKF, the prevalence of the disease varied from 17 to 48%<sup>32</sup> and in the Cardiovascular Health Study<italic>, </italic>the presence of PAD was an independent predictor of HF (RR = 1.61)<sup>33</sup>.</p>
      <p>Regarding dyslipidemia, there was no association between PAD and reported dyslipidemia and no significant difference was observed concerning the mean levels of cholesterol and triglycerides between the groups. The use of lipid lowering drugs was similar in the groups with and without PAD and must not have contributed to the lack of association between the variables. In the GetABI study, the power of the association between lipidic parameters and PAD was considered limited, when compared to the other cardiovascular risk factors<sup>34</sup>. It is noteworthy the fact that although 24.6% of the individuals with PAD reported dyslipidemia, only 4.5% used lipid lowering drugs.</p>
      <p>The prevalence of diabetes among individuals with PAD was 2.7-fold higher, when compared to individuals without PAD. The glycemia levels were slightly more elevated in the group with PAD; however, this difference did not have statistical significance. Diabetes is an important risk factor for the development of PAD. Studies that used the ABI to assess PAD among diabetic individuals demonstrated a prevalence of the disease between 20 and 29%<sup>26,35</sup>.</p>
      <p>Obesity was evaluated in this study based on the measurements of body mass index (BMI), abdominal circumference (AC) and waist/hip ratio (WHR). The BMI <underline>&gt;</underline> 30 as well as the increased WHR were associated with PAD, with the association between WHR and PAD more expressive among women. There was no association between AC measurement and PAD. Some studies have shown an association between PAD and abdominal obesity, but not with BMI, while others have shown an association between PAD and total and abdominal obesity only among women<sup>36,37</sup>.</p>
      <p>The prevalence of intermittent claudication was 7%. In the literature, the prevalence varies from 0.4% to 14%, depending on the age, sex, risk profile and the diagnostic method that was used<sup>2</sup>. Among those with PAD, the prevalence of claudication was only 9% and its presence was not associated with PAD. In a study that evaluated different ethnic groups, the prevalence of claudication was 7.5%<sup>38</sup>. As most of the individuals with PAD is asymptomatic or presents unspecific symptoms, the claudication questionnaires, useful to identify symptomatic patients, are inefficient to asses PAD, which reinforces the role of the ABI measurement in the assessment of populations that are at-risk for the occurrence of the disease.</p>
      <p>It is worth mentioning the association between the presence of pain or discomfort in the leg(s) during walking and PAD, even when the criteria for claudication have not been met, as such complaint was reported by more than half of the individuals with PAD, which suggests that its presence must be taken into account during the clinical assessment of these patients. Such finding had been previously described by our group in elderly individuals participating in the Epidoso study<sup>9</sup>.</p>
      <p> The absence of ankle pulses to palpation, especially of the posterior tibial pulses, was associated with PAD. The abnormalities in the posterior tibial pulses are more sensitive and specific for the presence of PAD than the abnormalities of the pedal pulses, as approximately 10% of the healthy population does not have these palpable pulses<sup>39</sup>.</p>
      <p>When we analyze the interaction between gender and the coexisting clinical conditions, we observed that the women with IHD included in the "Hearts of Brazil" Project presented an approximate 5-fold higher risk of having PAD than those without IHD, whereas diabetic men had a 6.6-fold higher risk of presenting PAD in comparison to nondiabetic ones. A possible explanation, in the case of the women, would be the trend to develop cardiovascular disease at an older age, due to the hormonal protection factor. The post-menopausal period could increase the chance of manifestations of vascular involvement in more than one territory. On the other hand, male sex and diabetes are two factors that have been associated with PAD at younger age ranges<sup>16</sup>.</p>
      <p>
        <bold>Clinical implications</bold>
      </p>
      <p>The data from the "Hearts of Brazil" Project raise a warning for the Brazilian medical community on the need to assess PAD in clinical practice. This warning is based not only on the elevated prevalence of PAD found in the study, but mainly in the expressive number of asymptomatic individuals (91%), who, if diagnosed early, could benefit from preventive measures to reduce the risk of acute myocardial infarction, stroke and cardiovascular death. The simple implementation of the ABI measurement as part of the assessment of patients with moderate and high cardiovascular risk would implicate in a significant impact on the early detection of asymptomatic individuals with PAD.</p>
      <p>
        <bold>Limitations</bold>
      </p>
      <p>This study was not designed with the objective of estimating the prevalence of PAD at city level, as in some of them the sample consisted of only 15 individuals, but at regional level. Its main limitation is not having enough sample power to be representative of he Brazilian population as a whole. Its power is enough to represent the Brazilian population of urban centers with more than 100,000 inhabitants, estimated as 57 million. A secondary limitation was that the complex study sample design excluded towns such as Marilia, Petropolis and Santa Maria from the analysis of the variable <italic>mean duration time of the physical activities, </italic>based on the insufficient number of valid individuals in the sample.</p>
      <p>
        <bold>Acknowledgements</bold>
      </p>
      <p>To the Board of the Brazilian Society of Cardiology (SBC) &#150; 2004/2005 term, especially SBC President, Dr. Ant&#244;nio Felipe Sim&#227;o.</p>
      <p>To the doctors, SBC members, nurses, medical and nursing students, nursing technicians, laboratory technicians who voluntarily participated in the 2<sup>nd</sup> phase of the study.</p>
      <p>To the Sponsors, Instructors, Investigators and Field Coordinators of the "Hearts of Brazil Project" listed in the Appendix available at:</p>
      <p><ext-link ext-link-type="uri" xlink:href="http://www.arquivosonline.com.br/2008/">http://www.arquivosonline.com.br/2008/</ext-link>.</p>
      <p>To the statisticians Elsa Cristina de Mundstock, M.Sc., Jandyra Maria Guimar&#227;es Fachel, Ph.D., and Vinicius Nunes Machado, B.Sc. in Statistics .</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
